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Abstract 
 
Neurons establish complex networks within the nervous system allowing 
for rapid cell-cell communication via their long, thin axonal processes.  These 
wire-thin projections are susceptible to a number of insults or injuries, and axonal 
damage can lead to disruption in signal propagation and an overall dysfunction of 
the neural network.  Recent research focused on investigating the underlying 
mechanisms of injury-induced axon degeneration led to the discovery of a 
number of endogenous, pro-degenerative molecules such as dSarm/Sarm1, 
Highwire/Phr1, and Axundead.  These signaling molecules are thought to 
execute axon degeneration in response to injury locally within the distal severed 
axon, but the exact mechanism of action is unclear. 
 To further identify novel participants of the axon death signaling cascade, 
we performed an unbiased forward genetic mutagenesis screen using the 
sensory neurons within the adult wing of Drosophila melanogaster.  We identified 
a novel role for the C2H2 zinc finger transcription factor, Pebbled (Peb)/Ras-
responsive element binding protein 1 (RREB1) in partially suppressing injury-
induced axon degeneration.  Loss of function peb mutant glutamatergic neurons 
present two distinct axon degeneration defects: either complete protection from 
axotomy, or they exhibit a novel phenotype in which axons fragment into long, 
continuous pieces instead of undergoing complete degeneration.  Additionally, 
we show an enhancement of the peb protective phenotype when dSarm levels 
	vi	
are decreased, but not with reduced levels of axundead.  These data provide the 
first evidence of a transcription factor involved in regulating injury-induced axon 
degeneration signaling in vivo. 
  
	vii	
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CHAPTER I: Introduction 
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Neurons and Their Networks 
The nervous system is a series of intricate, interconnected neural networks 
working cooperatively to send and receive messages throughout an organism.  
Sensory networks of the peripheral nervous system (PNS) relay a multitude of 
external environmental inputs to the central nervous system (CNS) for 
interpretation, further processing, and execution of a certain organism response.  
Overall, the nervous system of an organism can be divided into two broad 
classes of cells: neurons and glia.  Neurons are remarkable cells involved in fast, 
long-distance information communication and processing, while surrounding glial 
cells not only provide structural and metabolic support, but homeostatic functions 
as well (Freeman and Doherty, 2006).    
 Neurons are composed of four parts, each with distinct roles necessary for 
successful signal propagation.  Dendrites receive a number of inputs which are 
integrated in the cell body.  The signal is then transmitted down a long, relatively 
thin axon and relayed to a downstream effector cell through the axon terminal.  
Maintaining the health of each of these components is essential for proper neural 
circuit function within an organism.  Focusing specifically on the axon, their 
extreme length makes them particularly vulnerable to a number of insults and 
injuries.  Whether these insults may be intrinsic, such as defects in axon 
transport or energy depletion (Chevalier-Larsen and Holzbaur, 2006; Gilley and 
Coleman, 2010), or due to external physical lesions seen in axotomy and 
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traumatic brain injury (TBI)  (Waller, 1850; Johnson et al., 2013; Henninger et al., 
2016), they can all lead to axon loss and network dysfunction. 
 
Wallerian Degeneration 
Physical transection of the distal axon from the cell body leads to stereotypical 
degenerative process, known as Wallerian degeneration (WD).  This 
phenomenon was first discovered in 1850 by Augustus Waller when he severed 
the hypoglossal nerve in the tongue of a frog and recorded the morphological 
changes of the distal nerve over the course of the following two weeks.  Waller’s 
initial observations described the three distinct phases the distal axon underwent 
during the degenerative process.  Initially, the anatomy of the severed nerve 
remained unchanged, however, over time, Waller noted it began to appear “more 
varicose that usual”.  At the end of two weeks, all traces of the distal nerve were 
gone, appearing to have been “removed by absorption” (Waller, 1850).  
 Since Waller’s initial characterization, degeneration of the distal axon has 
been studied in depth and is well-characterized (Figure 1.1).  Immediately 
following injury, the membrane on both proximal and distal axons quickly reseal 
in a calcium-dependent manner (Eddleman et al., 1998) and form dystrophic 
end-bulbs due to the accumulation of retrograde and anterograde transport of 
proteins and organelles (Zelená et al., 1968; Wang et al., 2012).  The sudden 
influx of calcium ions (Ca2+) local to the injury site activates calpain proteases, 
required for breaking down the cytoskeletal proteins and effectively degenerating 
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hundreds of micrometers of the newly resealed axon membrane (George et al., 
1995; Kerschensteiner et al., 2005).  This process, known as “acute axon 
degeneration” (AAD), precedes a latent phase in which the distal axon remains 
quiescent and there are no gross morphological changes observed to the 
integrity of the axonal membrane.  A second slow influx of extracellular Ca2+ 
occurs throughout the entirety of the distal axoplasm, initiating the final 
destructive phase of WD. Similar to AAD, cytoskeletal proteins spectrin, 
microtubules and neurofilaments are broken down by calpain proteases 
(Johnson et al., 1991; Ma et al., 2013), resulting in mitochondrial swelling, energy 
depletion, and ultimately complete and explosive fragmentation of the detached 
axon fragment (Wang et al., 2012; Park et al., 2013).  Over time, the lingering 
axonal debris is cleared from the environment by engulfment from surrounding 
phagocytes (MacDonald et al., 2006; Doherty et al., 2009).  
Calcium has been proven to play a critical role in the execution of WD.  
Pharmacological calpain inhibitors or overexpression of the endogenous calpain 
inhibitor, calpastatin, modestly delay axon degeneration after axotomy (Yang et 
al., 2013; Zhang et al., 2016). Similar effects are seen in vitro when extracellular 
calcium concentrations are decreased by use of chelating agents such as 
ethylene glycol tetraacetic acid (EGTA), or inhibiting axonal calcium influx by 
chemical antagonists to L-type calcium channels, as they are sufficient to block 
the final stage of fragmentation of the axon (Schlaepfer, 1974; George et al., 
1995; Ma et al., 2013; Vargas et al., 2015).  Conversely, facilitating the influx of 
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intracellular Ca2+ by addition of different calcium ionophores (ionomycin and 
A23187) in vitro is sufficient to quickly drive axon degeneration in the absence of 
injury (Schlaepfer and Hasler, 1979; George et al., 1995; Knoferle et al., 2010).  
Together these data indicate calcium is necessary and sufficient to drive 
degeneration and that the execution of the final phase of WD is dependent on the 
influx of Ca2+ ions after injury. 
 
Axon Death Can Be Blocked 
After Waller’s groundbreaking discovery in 1850, it was widely accepted that 
transected axons undergo passive degeneration – that is to say, they simply 
waste away.  Many postulated that, due to the separation of the distal axon from 
the nutrient providing cell soma, established reservoirs of essential “survival 
factors” fell below a critical threshold inducing a self-destructive process 
(Lubińska, 1977).  This idea of passive axonal atrophy held true for nearly 150 
years, until the serendipitous discovery of the novel mutant mouse strain, 
C57BL/Ola, changed how the field viewed injury-induced axon degeneration. 
When sciatic nerves of these mice were severed, distal axons within the nerve 
bundle remained morphologically intact for weeks, compared to wild-type mice 
whose axons began to degenerate within hours of injury.  Not only were the 
axons of the C57BL/Ola mice physically unchanged, but they proved to have the 
capacity to conduct action potentials up to 14 days after injury. Conduction of 
action potentials within severed wild-type nerves failed after only 2 days (Lunn et 
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al., 1989).  The opportune discovery of this spontaneous mutation provided the 
first evidence that WD could be blocked.   
 The C57BL/Ola mouse strain, aptly renamed Wallerian degeneration Slow 
(WldS), harbored a mutation that mapped to chromosome 4 (Lyon et al., 1993).  
The nature of the mutation was found to be an 85-kb tandem triplication of the 
genome (Coleman et al., 1998) whose rearrangement resulted in the fusion of 
two genes, which when expressed, generated a novel chimeric protein. The 
neomorphic WldS protein is comprised of 3 distinct domains.  The N-terminal 70 
amino acids (N70) stem from the truncated N-terminus of the E4-type ubiquitin 
ligase, Ube4b, followed by a novel 18 amino acid peptide sequence generated 
from the 5ʹ untranslated region (UTR) of the nicotinamide adenine dinucleotide 
(NAD) biosynthetic enzyme, nicotinamide mononucleotide adenylyltransferase 1 
(nmnat1).  The C-terminal 285 amino acids compose the functional, full-length 
Nmnat1 protein (Mack et al., 2001).  The WldS protective phenotype is dosage-
dependent, as transgenic animals expressing higher levels of WldS display 
stronger levels of axon protection compared to lower expressing animals (Mack 
et al., 2001).  WldS is functionally conserved across species; not only does over-
expression of the WldS protein provide robust axon protection from injury in other 
vertebrate models such as rats (Adalbert et al., 2005), zebrafish (Martin et al., 
2010), and human neurons (Kitay et al., 2013), WldS also inhibits degeneration in 
Drosophila models of WD (MacDonald et al., 2006; Xiong et al., 2012; Neukomm 
et al., 2014).  
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 To understand how WldS preserves axons after injury, we must first look at 
each of its domains independently.  In yeast, Ube4b is essential for the multi-
ubiquitination of proteins and is a key component of the ubiquitin proteasome 
system (UPS) (Koegl et al., 1999; Hoppe, 2005).  Blocking the UPS with a 
pharmacological inhibitor, MG132, is sufficient to delay, but not inhibit WD 
completely, both in vitro and in vivo (Zhai et al., 2003).  While N70 of WldS does 
not retain the ability to ubiquitinate, it can bind known Ube4e substrates.  
Specifically, N70 interacts directly with the AAA+ (ATPases Associated with 
diverse cellular Activities) ATPase family member vasolin-containing protein 
(VCP), and this association regulates the subcellular distribution of WldS, re-
localizing it from the nucleus to the axoplasm (Laser et al., 2006; Wilbrey et al., 
2008; Avery et al., 2009).  Specific overexpression of the N70 domain can mildly 
delay axon degeneration in vitro (Zhai et al., 2003).  N70’s inability to ubiquitinate 
its substrates is thought to have a dominant negative effect on the UPS, resulting 
in defective axon degeneration after injury.    
 The C-terminal domain of WldS encodes the full-length Nmnat1 gene 
(Mack et al., 2001).  Initial characterizations of the WldS mouse indicate a marked 
increase of Nmant1 enzymatic activity without showing any alterations to the 
overall steady-state of NAD+ levels (Mack et al., 2001).  Multiple studies confirm 
these findings and give evidence that the enzymatic activity of Nmnat1 is 
required for the protective nature of the WldS mutation, as mutations in the 
catalytic domain of Nmnat1 within WldS render the protein inactive in the context 
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of axon protection. (Araki, 2004; Wang et al., 2005; Avery et al., 2009; Sasaki 
and Milbrandt, 2010).  Interestingly, overexpression of Nmnat1 is significantly 
weaker at protecting axons from degenerating in vitro and in vivo, as compared 
to WldS mutant and transgenic mice (Conforti et al., 2007).  Furthermore, 
decreasing expression levels of Nmnat1 in Nmnat heterozygous mice shows no 
effect on the rate of WD (Conforti et al., 2011).  Together, these data suggest 
Nmnat1 activity is necessary but not sufficient to phenocopy the robust protective 
phenotype of WldS. 
 In mammals, there are three paralogs of Nmnat: Nmnat1, Nmnat2, and 
Nmnat3.  Nmnat1 is expressed in the nucleus, whereas Nmnat2 and Nmnat3 
localize to the Golgi and mitochondria, respectively (Zhang et al., 2003; Berger, 
2005; Mayer et al., 2010).  As previously mentioned, overexpression of Nmnat1 
alone could not offer axonal protection, however when the nuclear localization 
signal is disrupted, Nmnat1 translocates to the cytoplasm where it phenocopies 
the protective nature of WldS (Beirowski et al., 2009).  This is not surprising since 
the direct interaction with VCP relocates WldS outside of the nucleus (Wilbrey et 
al., 2008).  These findings suggest the protective mechanism of action of WldS 
occurs in the cytoplasm and requires both the enzymatically active Nmnat1, and 
the N70 Ube4b substrate binding domain to prevent degeneration.   
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Nmnat2: The Essential Survival Factor Hypothesis, Revisited  
The finding that cellular redistribution of Nmnat1 from the nucleus to the 
cytoplasm robustly protects axons after injury reinvigorated the previously 
dismissed essential survival factor hypothesis; that is, separation of the distal 
axon from the cell body inhibits the anterograde transport of trophic factors 
required for axon survival.  Since Nmnat1 expression is restricted to the nucleus, 
researchers turned their attention towards the other Nmnat homologs, Nmnat2 
and Nmnat3, assaying their role in axon degeneration.  Overexpression of any of 
the three proteins were sufficient to protect axons from degeneration only if they 
are translocated to the cytoplasm (Beirowski et al., 2009; Yahata et al., 2009; 
Avery, 2010; Gilley and Coleman, 2010).  Conversely, only depletion of 
endogenous Nmnat2 by short interfering RNA (siRNA) knockdown in mouse 
superior cervical ganglia (SCG) and dorsal root ganglia (DRG), was sufficient to 
trigger axon degeneration in the absence of injury.  Both knockdown of Nmnat1 
and Nmnat3 had little effect on the health and morphology of the axons (Gilley 
and Coleman, 2010).  Similarly, overexpression of Nmnat1 or Nmnat3 was not 
sufficient to compensate for the loss of Nmnat2 by siRNA knockdown, as 
cultured neurons still degenerated.  Taken together, these data provide 
substantial evidence that Nmnat2 is required for promoting and maintaining the 
survival of the axon.  
To confirm Nmnat2 is provided by the cell body and not synthesized 
locally within the distal axon, nascent protein synthesis was blocked in vitro by 
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local application of a pharmacological translational inhibitor, cyclohexamide 
(CHX), using compartmentalized Campenot cell culture chambers (Campenot, 
1977).  CHX application only to cell bodies but not neurites of SCG cultures 
induced axon degeneration.  Therefore, maintenance and survival of the axon 
depends on the anterograde transport of Nmnat2 translated within the cell body 
(Gilley and Coleman, 2010).  
Nmnat2 is the most labile of the three Nmnat isoforms, with an observed 
half-life of approximately 4 hours in vitro (Gilley and Coleman, 2010).  
Coincidentally, this correlates precisely with the onset of axon degeneration in 
vitro.  Blocking the transport of Nmnat2 to distal axons either by physical 
transection or by pharmacologically inhibiting nascent translation of Nmnat2, 
identifies Nmnat2 as an essential protein in axon maintenance and supports its 
role in the essential survival factor hypothesis of WD.  
 
Drosophila as a Model Organism 
The initial identification of the WldS gene turned the axon degeneration field on its 
head. No longer was WD thought to be a simple, passive cellular process, but in 
fact it could be blocked by overexpressing the WldS protein.  The notion that 
axons can persist for weeks in the absence of support from their cell bodies 
implied there may be an intrinsic pathway signaling an axon to degenerate upon 
injury, but the key players regulating this process remained unknown.  Identifying 
these endogenous regulators required a model organism that was suitable for 
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large scale in vivo genetic screens, one that was simple to work with, and most 
importantly, one in which the process of WD was conserved. Satisfying these 
criteria made Drosophila melanogaster an excellent model organism to 
investigate the genes that execute WD in vivo.  
A wide array of sophisticated tools available allow for simple, yet elegant 
genetic manipulations in Drosophila.  The GAL4-UAS (upstream activating 
sequence) binary system, originally identified in the yeast Saccharomyces 
cerevisiae, allows for tissue specific labeling (Duffy, 2002).  Protein expression of 
the GAL4 transcriptional activator is regulated by surrounding enhancer elements 
within the Drosophila genome. GAL4 will bind UAS and drive expression of a 
downstream gene of interest in a tissue specific manner.  Using this technique, 
we can label specific subsets of cells with fluorescent markers or even ectopically 
express proteins for analysis in small or large subsets of cells. 
A second advantage of using Drosophila as a model organism is the ease 
with which unbiased, forward genetic screens can be performed in vivo.  The 
common chemical mutagen ethyl methane sulfonate (EMS) randomly induces 
mutations within the genome, primarily with a bias towards guanine/cytosine to 
adenine/thymine transitions (St Johnston, 2002; Bökel, 2008).  These lesions can 
result in frameshift mutations, missense mutations, truncated peptides due to the 
introduction of premature stop codons, or even small genomic deletions. To 
avoid lethality when mutating essential genes, screens can be performed 
employing mosaic analysis with a repressible cell marker (MARCM) (Lee and 
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Luo, 2001). MARCM uses the Gal4/UAS binary system along with the Gal4 
repressor (GAL80), in combination with homologous recombination via the 
flippase recombinase (FLP) and FLP recognition target (FRT) system (Golic and 
Lindquist, 1989). After induction of post-mitotic FRT recombination by tissue 
specific FLP expression, a population of GAL4 expressing cells will be 
homozygous mutant in the otherwise heterozygous background of the animal.  
Combined, these genetic tools and techniques set the stage to investigate 
mechanisms of WD in Drosophila. 
 
Modeling Wallerian Degeneration in Drosophila 
The first experiments modeling WD in Drosophila fluorescently labeled a 
subset of olfactory receptor neurons (ORNs) in the adult using the OR22a-GAL4 
driver (Dobritsa et al., 2003; MacDonald et al., 2006).  The cell bodies of these 
peripheral neurons reside in the distal most antennal segments, project their 
axons into the head capsule and synapse within specific glomeruli of the 
neuropil, called the antennal lobe.  To model WD, antennae were mechanically 
ablated, severing the distal axons from their respective cell bodies.  The distal 
axons within the head undergo the stereotyped degenerative process in which 
they fragment 24 hours post axotomy and are cleared by the surrounding glia 
within 3 days (MacDonald et al., 2006).  As mentioned in previous sections, this 
WD is completely blocked by the ectopic expression of WldS (Avery et al., 2009; 
MacDonald et al., 2013).  The development of this ORN system and the ability to 
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perform large-scale, forward genetic screens in Drosophila that led Osterloh et al. 
to discover dsarm (Drosophila sterile-α and Armadillo motif), the first gene shown 
to be essential for the execution of WD (Osterloh et al., 2012). 
A second model of WD, the larval nerve crush, takes advantage of an 
earlier stage of development in Drosophila.  Segmental nerves bridge the 
connection between the body wall and the ventral nerve cord (VNC) of the animal 
and contain both efferent motor neurons and afferent sensory neurons (Xiong et 
al., 2010; Rooney and Freeman, 2014).  In this model, fluorescently labeled 
segmental nerves are easily visualized in vivo along the ventral side of the 
animal through the thin, transparent cuticle.  To simulate injury, the nerves are 
firmly compressed using forceps, typically resulting in the paralysis of the animal 
posterior to the crush site (Xiong et al., 2010).  By taking a combinatorial 
approach, first using larval crush and then the ORN assay, Xiong et al. 
discovered that a mutation in highwire (hiw), a gene encoding an E3 ubiquitin 
ligase, protected axons from WD (Xiong et al., 2012).  This crush model is ideal 
for not only studying WD in the distal axon segment, but also cellular responses 
in the proximal axon or cell body, degeneration of synapses at the 
neuromuscular junction (NMJ), and peripheral neuron regeneration.  While the 
larval nerve crush facilitates the study of these aspects of degeneration, 
however, one limiting factor of the system is its short time-frame (2-3 days) to 
make observations before the animal undergoes metamorphosis (Hales et al., 
2015).  
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The time-consuming nature of ORN ablation and the restrictive 
developmental window associated with the larval nerve crush inspired the 
development of a new model to study WD in Drosophila – the adult wing.  
Mechanosensory neuron specific GAL4 drivers can label different subpopulations 
of the 250 neurons within the adult wing (Fang et al., 2012; Neukomm et al., 
2014).  The cell bodies of these mechanosensory neurons position themselves 
throughout the L1 vein along the anterior margin of the wing, projecting their 
axons into the thoracic ganglia.  Similar to the larval nerve crush, the 
transparency of the wing cuticle allows for visualization of the fluorescently 
labeled neurons without labor intensive dissections or time consuming antibody 
staining required for the ORN assay.  The wing is simply cut in half, injuring most 
of the labeled neurons and inducing degeneration, while those neurons that 
remain uninjured serve as internal controls.  As such, WD can be studied along-
term neuron maintenance within the same wing.  
 
dSarm/Sarm1 Regulates Wallerian Degeneration 
In 2012, a large-scale forward genetic screen using the Drosophila ORN system 
identified dsarm as the first endogenous regulator of WD in vivo. (Osterloh et al., 
2012).  Injury-induced degeneration is strongly inhibited in dsarm mutant axons 
and morphologically preserved axons are present for the life of the animal (~50 
days) (Osterloh et al., 2012).  Importantly, the axon protective phenotype is 
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conserved in mammals and can be observed in vitro and in vivo.  DRG explants 
from Sarm1-/- mice are protected from degeneration for 72 hours after injury in 
vitro, while distal nerve bundles from lesioned sciatic nerves display 
morphologically intact axons up to 2 weeks post-injury in vivo (Osterloh et al., 
2012; Gerdts et al., 2013). dsarm/Sarm1 appears to function specifically in the 
axonal injury response, as loss of function mutations do not influence normal 
developmental pruning, induced apoptosis, or trophic factor withdrawal (Osterloh 
et al., 2012; Gerdts et al., 2013). 
  dSarm/Sarm1 is a member of the toll/interleukin-1 receptor (TIR) domain 
adaptor protein family (O'Neill and Bowie, 2007) and was initially discovered to 
be a negative regulator of NF-κB and interferon-regulatory factor (IRF) activation 
during immune response signaling (Carty et al., 2006).  Involved not only in 
immune signaling, the Caenorhabditis elegans homolog, tir-1, gives evidence 
that Sarm proteins signal to downstream mitogen-activated protein kinase 
(MAPK) cascades to regulate a number of cellular processes (Mink et al., 2001; 
Chuang and Bargmann, 2005).  dSarm/Sarm1 protein consist of multiple 
domains, each with distinct predicted functions.  Structure-function studies 
indicate the N-terminal Armadillo/HEAT domain (ARM) acts as an auto-inhibitory 
domain, blocking active Sarm signaling until released by an unknown factor 
(Chuang and Bargmann, 2005; Gerdts et al., 2011; Neukomm et al., 2017).  Two 
tandem sterile-α motif domains (SAM) establish protein-protein interactions and 
are necessary for the multimerization of Sarm molecules (Kim and Bowie, 2003; 
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Chuang and Bargmann, 2005; Gerdts et al., 2013).  Finally, the C-terminal 
toll/interleukin-1 receptor homology domain (TIR) domain executes the 
communications to the downstream effector proteins in the signaling cascade 
(Chuang and Bargmann, 2005; O'Neill and Bowie, 2007; Gerdts et al., 2013).   
 As axonal NAD+ levels and Nmnat2 activity have previously been 
implicated as important factors involved in axon degeneration.  Recent research 
has attempted to identify potential correlations with between dSarm/Sarm1 and 
these molecules, but the results are conflicting.  Elegant in vitro experiments 
show rapid depletion of NAD+ levels within minutes of the activation of Sarm1-
induced degeneration, later proven to be due to an intrinsic NADase activity 
within the SAM-TIR domains of the Sarm1 protein (Gerdts et al., 2015; Essuman 
et al., 2017).  Resupplying NAD+ by increased cytoplasmic Nmnat2 enzyme 
activity can sufficiently block Sarm1-induced axon degeneration, suggesting 
Sarm1 acts upstream of Nmnat2 (Gerdts et al., 2015).  In Drosophila, 
spontaneous degeneration caused by dnmnat loss of function is suppressed in 
axed, but not dsarm, mutant neurons.  This places dSarm genetically upstream 
of nmnat.  In contrast to these data, in vivo studies of Nmnat2-/- show perinatal 
lethality is completely rescued in Nmnat-/-, Sarm1-/- double mutant mice.  These 
double knockout mice develop normally, are viable, and exhibit no overt axon 
morphology or behavioral phenotypes, suggesting Sarm1 is epistatic to Nmnat2 
(Gilley et al., 2015; 2017).  Therefore, further investigation is required to fully 
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understand where Nmnat2 functions in the current axon death pathway (Figure 
1.2). 
 
Highwire/Phr1 Controls Axonal Nmnat2 Levels  
Highwire is an E3 ubiquitin ligase and was the second endogenous regulator of 
injury-induced axon degeneration to be discovered.  Loss of hiw confers 
significant protection from nerve crush in segmental nerves within the Drosophila 
larva, as well as in ablated ORN in the adult antennae (Xiong et al., 2012).  Hiw 
mutant nerves are both morphologically and functionally preserved, as they still 
produced spontaneous excitatory junction potentials 24 hours after crush (Xiong 
et al., 2012).  Similar to dsarm/Sarm1, the loss of Phr1 (Proteins associated with 
Myc, Hiw, RPM-1), the mammalian homolog of hiw, modestly protects axons 
from WD both in vivo and in vitro (Babetto et al., 2013).   
 Structurally, Hiw is a large protein (larger than 400kDa) and is comprised 
of the following domains: RCC1-like GEF domain (RLD), two PHR family specific 
domains, an RAE-1 binding domain (RBD), an FSN-1 binding domain 1 (FBD1) 
and a really interesting new gene (RING) ubiquitin ligase domain (Grill et al., 
2016).  Together, these domains are required to modulate a number of cellular 
processes regulating synaptic growth and development, cytoskeletal stabilization, 
axon guidance, as well as degeneration and regeneration (Wan et al., 2000; 
McCabe et al., 2004; Massaro et al., 2009; Shin and DiAntonio, 2011; Fang and 
Bonini, 2012; Grill et al., 2016). 
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 In the context of degeneration, Phr1 limits levels of axonal Nmnat2 
through association with members of an atypical Skp/Cullin/F-box (SCF) type E3 
ubiquitin ligase complex (Yamagishi and Tessier-Lavigne, 2016). Nmnat2 levels 
were found to be increased in neurites of both Phr1-/- and Skp1a knockdown 
DRG explants (Babetto et al., 2013; Yamagishi and Tessier-Lavigne, 2016). 
Decreasing Nmnat2 levels by short hairpin RNA (shRNA) in Phr1-/- DRG explants 
reversed the protective phenotype and induced spontaneous degeneration 
(Babetto et al., 2013). Phr1 drives axon degeneration through regulation of the 
axoplasmic concentration of Nmnat2, while mutations in hiw/Phr1 result in the 
stabilization and accumulation of Nmant2, promoting to axon survival. 
Similarly, through ubiquitination, Hiw/Phr1 also regulates the levels of dual 
leucine kinase/wallenda (dlk/wnd), a MAP kinase kinase kinase (MKKK) shown 
to promote axon degeneration after injury (Miller et al., 2009; Xiong et al., 2010).  
Loss of function mutations in dlk/wnd show mild protection from axotomy, a weak 
phenotype most likely due to compensation from other redundant members in the 
MAPK/JNK signaling pathway.  In vitro data from mammalian DRG axotomy 
experiments shows modest protection of axons after injury only when there is 
knockdown of both MKK4/MKK7 (MAP kinase kinase 4/ MAP kinase kinase 7) or 
all three JNK signaling molecules (JNK1/JNK2/JNK3) simultaneously (Yang et 
al., 2015). 
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Axundead Signals Downstream of dSarm in Axon Death 
Most recently, Neukomm and Burdett et al. identified axundead (axed) as the 
third novel gene proven to endogenously regulate injury-induced axon 
degeneration (Neukomm et al., 2017).  In Drosophila, axed encodes a protein 
with two primary domains.  The broad-complex, tramtrack, bric-a-brac (BTB) 
domain is canonically involved in protein-protein interactions as well as 
multimerization (Bardwell and Treisman, 1994; Chaharbakhshi and Jemc, 2016).  
As for the BTB and C-Terminal Kelch (BACK) domain, it has been shown to bind 
various substrates, however not much else is known (Stogios and Privé, 2004; 
Chaharbakhshi and Jemc, 2016).  BTB-Kelch proteins aid the Cullin3-based-
ubiquitin ligase complex recognize substrate proteins targeted for proteasome 
degradation (Pintard et al., 2004), further corroborating the involvement of the 
UPS in WD.  
Axed mutant neurons demonstrate complete inhibition of WD for the life of 
the animal, a level of protection that rivals dsarm mutants.  Similar to dsarm, 
there is no apparent bias towards specific neuronal subtypes, as axon 
degeneration was blocked in all neurons assayed.  Loss of function axed mutants 
are capable of blocking gain of function dSarmΔARM induced degeneration, 
indicating that dSarm signals through Axed to execute axon death.  Epistatic 
analysis between axed and the Drosophila Nmnat2 homolog dnmnat (Drosophila 
only have one Nmnat isoform, where mammals have three) places axed 
downstream of Nmnat as axed mutants completely suppress Nmnat depletion 
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induced degeneration (Neukomm et al., 2017).  These data together indicate the 
known WD and axon degeneration signaling cascades converge on Axed to 
execute axon degeneration (Figure 1.2).  
 
Pebbled, a C2H2 Zinc Finger Transcription Factor 
Pebbled (peb), also annotated as hindsight (hnt) in previous literature, encodes 
an evolutionarily conserved zinc finger transcription factor required for various 
cellular processes during Drosophila development, including, but not limited to: 
large scale epithelial cell movement, cell polarity and recently identified, axon 
guidance (Yip et al., 1997; Pickup et al., 2002; Oliva et al., 2015).  Peb 
expression is restricted to the nucleus and can be found within specific tissues of 
the developing embryo, such as the amnioserosa (AS), anterior midgut, and 
posterior midgut.  As the animal enters later stages of development.  The Peb 
expression pattern changes and is present in the trachea, peripheral nervous 
system, and neuronal precursors within the imaginal discs (Yip et al., 1997; 
Pickup et al., 2002), however Peb remains undetectable in the CNS throughout 
development (Oliva and Sierralta, 2010).  peb is an essential gene, as loss of 
function peb mutants fail to develop correctly, resulting in lethality (Strecker and 
Yip, 1991; Yip et al., 1997; Reed et al., 2001). 
Structurally, Peb is 1893 amino acids long, contains two predicted α-
helical coiled-coil domains and fourteen zinc finger motifs clustered along the 
length of the protein (Yip et al., 1997). The two α-helical coiled-coil domains are 
	21	
predicted to be involved in protein-protein interactions, while the zinc finger 
domains are predicted to bind target DNA (Figure 1.3).  Peb is a member of the 
Cys2-His2 (C2H2) zinc finger protein family.  The C2H2 domain is the founding 
member of the zinc finger domain containing proteins and is the most common 
motif across all zinc finger proteins (Razin et al., 2012).  Within each motif, a zinc 
ion forms four bonds between the two N-terminal cysteine residues and the C-
terminal histidine residues, and the domain assumes a finger-like protrusion.  
This “finger” associates with and grasps the major groove of its target DNA 
sequence (Wolfe et al., 2000; Klug, 2010).  The α-helical domain within each 
finger is capable of recognizing and binding to three nucleotide base pairs within 
the groove, and it is amino acids -1, 3, and 6 within the α-helix that determine the 
DNA sequence specificity (Razin et al., 2012). 
 Peb was initially identified in AS maintenance and is required for germ 
band retraction, a developmental process involving large-scale changes in cell 
shape, morphology, and ultimately tissue rearrangement within the embryo 
(Frank and Rushlow, 1996; Yip et al., 1997; Lynch et al., 2013).  During normal 
development, the germ band elongates as cells reposition themselves along the 
anterior-posterior axis, displacing the AS cells in a process known as germ band 
extension.  The tightly associated AS cells, compressed along the dorsal-ventral 
axis and now sandwiched between the fully extended germ band, return to their 
original position facilitating the shortening and retraction of the germ band (Frank 
and Rushlow, 1996; Schöck and Perrimon, 2002).  Embryos with loss of peb 
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expression in the AS cells fail to undergo proper germ band retraction, resulting 
in an over extended, U-shaped germ band phenotype, ultimately leading to 
premature loss of AS cells (Frank and Rushlow, 1996; Lamka and Lipshitz, 
1999).  
 Following germ band retraction, a second developmental process 
requiring peb is dorsal closure, or the elongation and migration of dorsal 
epithelial cells over the exposed AS of the embryo.  Proper dorsal closure 
requires both focal adhesion complex formation as well as c-Jun N-terminal 
Kinase (JNK) signaling within the leading edge of the dorsal epithelial cells (Reed 
et al., 2001; 2004). Prior to the commencement of dorsal closure, a sudden spike 
in JNK signaling levels occurs in AS cells then drastically decrease in a peb 
dependent manner.  Peb is found to positively regulate expression of puckered 
(puc), the JNK phosphatase, thus reducing levels of active JNK signaling 
specifically within AS.  It is this establishment of a low-high boundary of JNK 
signaling between the AS and the leading edge of the migrating dorsal epithelium 
that permits focal adhesion formation required for efficient cellular migration 
(Llense and Martín-Blanco, 2008).  AS cells of peb mutants retain high JNK 
signaling and inhibit the establishment of focal adhesions, resulting in dorsal 
closure failure (Reed et al., 2001). 
 Peb has been shown to regulate cellular proliferation and differentiation 
through Notch and Hedgehog (Hh) signaling.  Follicular epithelial cells covering 
the germline stereotypically undergo a series of mitotic cellular divisions (M 
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cycle) then switch to an endo-replication cycle (E cycle) prior to differentiation.  
This M/E cell cycle conversion requires Notch-Delta signaling, and disruptions in 
this signaling cascade results in over-proliferation or premature differentiation of 
the follicle cells (W M Deng, 2001).  Peb mutant follicle cells fail to downregulate 
expression of known Notch signaling molecules required for the M/E cycle 
switch, cut and string, and cannot successfully transition between the M/E cycle.  
Conversely, cells ectopically expressing Peb prematurely differentiate by 
inhibiting cell proliferation through indirect suppression of Hh (Lum and Beachy, 
2004; Sun and Deng, 2007).  
 More recent work has identified Peb’s role in regulating axon guidance.  
Firstly, overexpression and mosaic knockdown of Peb in larval and adult visual 
systems results in the mistargeting of photoreceptor axons to their correct 
destinations (Oliva and Sierralta, 2010).  This overshooting of axon terminals is a 
result of the altered expression levels of jitterbug/Filamin (jbug), the actin binding 
protein, and other axon guidance and cytoskeletal regulating proteins (Oliva et 
al., 2015).  Secondly, biochemical assays and chromatin immunoprecipitation 
(ChIP) data demonstrate Peb directly binds to and acts as a negative regulator to 
nervy (nvy) in the larval salivary gland (Ming et al., 2013).  nvy, the Drosophila 
homolog of the mammalian proto-oncogene myeloid translocation gene 8 
(MTG8), has a predominantly nuclear expression pattern, but is implicated in a 
non-canonical cytoplasmic role regulating axon guidance (Terman and Kolodkin, 
2004).  In the cytoplasm, Nvy acts as a kinase anchoring protein (AKAP), 
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coupling the cyclic adenosine monophosphate (cAMP) dependent protein kinase 
(PKA) to the Semaphorin 1a (Sema-1a) receptor Plexin A (PlexA) (Terman and 
Kolodkin, 2004).  
 
Thesis Overview 
The overall goal of this thesis was to identify previously unidentified genes 
required to drive WD in vivo.  To do so, I participated in a large-scale, unbiased, 
forward genetic screen using the Drosophila adult wing to model and identify 
regulators of WD.  In CHAPTER II, I describe the setup and execution of the wing 
screen in which we identified peb and alleles of other genes as regulators of WD.  
CHAPTER III focuses on a detailed characterization of peb mutants and their role 
in WD, the identification of a novel degenerative phenotype, and cell type 
specificity of axon protection after injury.  CHAPTER IV is a discussion of how 
Peb adds to the current model of axon degeneration and novel questions that 
arise with this discovery.  Finally, in the appendices, I present the data generated 
from two other projects: the gain of function dSarmΔARM suppressor screen, 
and observations of abnormal dendrite morphology in loss of function peb wing 
sensory neurons.    
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Figures & Tables
 
Figure 1.1. Transected Axons Undergo Stereotyped Degeneration.  
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Figure 1.1. Transected Axons Undergo Stereotyped Degeneration.  
Schematic representing the different stages of Wallerian degeneration in vivo.  
The distal axon is separated from the proximal cell body by local injury.  Within 1 
hour post axotomy, both proximal and distal axon stumps form dystrophic 
endbulbs and degenerate a few hundred micrometers in a process called acute 
axon degeneration (AAD).  Following a latent phase lasting 24-48 hours in which 
there are no gross morphological changes, the distal axon segment loses 
structural integrity and undergoes an explosive fragmentation event. Surrounding 
macrophages (green cells) actively engulf the axonal debris over the course of 
the next few days, with full clearance approximately 5 days post axotomy. 
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Figure 1.2. Current Model of Injury-Induced Axon Degeneration Signaling. 
Schematic describing the current model of intra-axonal signaling after injury with 
both pro-degenerative molecules (red) and protective molecules (green). 
External injury activates a local, pro-degenerative dSarm/Sarm1-Axed signaling 
cascade within the distal axon, while simultaneously inhibiting transport of 
nascent dNmnat/Nmnat2 molecules from the cell soma. Hiw/Phr1 regulates 
axonal dNmnat/Nmnat2 levels by targeting it to the proteasome for degradation. 
The exact placement of dNmnat/Nmnat2 in this pathway remains controversial, 
as there are conflicting data placing it both upstream and downstream of 
dSarm/Sarm1.  
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Figure 1.3. Protein Structure of Pebbled.  
pebbled encodes the zinc finger transcription factor Pebbled.  It is a 1,893 amino 
acid long protein and contains fourteen Cys2-His2 (C2H2) zinc finger binding 
motifs (gray ovals) as well as two predicted coiled-coil domains (red squares).  
(Diagram adapted from Ming et al., 2013, with permission from Differentiation) 
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CHAPTER II: Screening for Endogenous Regulators of  
Wallerian Degeneration 
 
This work in this chapter was conducted in the laboratory of Marc Freeman at the 
University of Massachusetts Medical School.  I performed a forward genetic 
screen, alongside Lukas Neukomm, Thomas Burdett, and Elizabeth Allen. Lukas 
Neukomm established the wing system and built all necessary Drosophila lines 
required for the screening of chromosomes 1, 2, and 3.  While I was 
unsuccessful in isolating a mutant allele from this screen, Thomas Burdett 
identified the peb345x allele, which I characterized and is the focus of work 
described in CHAPTER III.  The other mutant alleles identified from this screen 
are described in the following publications: 11 hiw alleles – Neukomm et al., 
PNAS 2014; 1 dsarm4314, axed0011, and axed2094 – Neukomm and Burdett et al., 
Neuron 2017.   
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Abstract 
 
The ability to perform powerful forward genetic screens in Drosophila makes it 
possible to identify genes involved in the regulation of certain biological 
processes.  One such example is the recent discovery of dsarm as the first 
endogenous regulator of Wallerian degeneration (WD) in vivo.  With this new 
evidence of an intrinsic axon death mechanism, we sought to identify other 
genes involved in the injury-induced dSarm signaling cascade, however the 
established model of antennal ablation to cause WD is time consuming, low-
throughput, and labor intensive.  Using a newly established adult wing model of 
WD, we screened through over 40,000 chromosome arms and isolated a number 
of mutant alleles, including two novel genes, shown to regulate axon death after 
injury. In the work in this chapter will describe the initial set-up, execution, and 
preliminary identification of alleles generated from the mutagenesis screen. 
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Results & Discussion 
 
Unbiased Mutagenesis Screening in the Drosophila Adult Wing 
Using the wing model of WD previously established in the Freeman Lab 
described in Neukomm et al., 2014, we sought to identify and characterize novel 
genes involved in the regulation of axon degeneration after injury.  In this model, 
we fluorescently label a subset of peripheral mechanosensory neurons within the 
adult wing by expressing membrane-tethered green fluorescent protein (GFP) 
under the expression of the glutamatergic specific driver, OK371-GAL4.  OK371-
GAL4 labels approximately 40 neurons within the L1 vein of the wing, however, 
the high number of GPF+ axons make injury quantifications difficult.  To avoid this 
problem, we use MARCM to generate a low number of glutamatergic clones, 
allowing for single cell resolution.  Briefly, we induce post-mitotic homologous 
recombination between FRT sites on independent chromosomes through the 
expression of FLP under the promoter of the neural precursor, asense (ase-FLP).  
A series of ase-FLP were generated by random insertion throughout the 
Drosophila genome by mobilization, with each new insertion having a different 
level of expression.  Ase-FLP expression was tested for optimal clone induction 
for each chromosome arm (FRT19A, FRT40A, FRTG13, FRT2A, and FRT82B). 
 The fast and simple readout of the wing model of axotomy makes it an 
ideal system to look for suppressors of axon death.  Taking advantage of the 
transparent nature of the wing, we can image the axons of GFP+ neurons directly 
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through the cuticle in uninjured wings (Figure 2.1A).  To simulate WD, wings of 
live, anesthetized animals are surgically cut in half and aged for 7 days, allowing 
for axon degeneration and debris clearance to occur (Figure 2.1B).  The aged, 
injured wings are removed from the animal and processed for imaging.  Axons 
present in the proximal wing are quantified as well as the cell bodies of neurons 
that were not injured.  Under normal WD conditions, the ratio of axons:cell bodies 
will be 1:1.  Animals from the screen that have mutations in genes required for 
WD will have a greater number of axons as compared to the number of cell 
bodies present. 
Two types of forward genetic screens, F2-based and F1-based, are 
required for coverage of the X chromosome and both autosomes, respectively 
(Figure 2.2).  For assaying WD suppressors on the X chromosome, we were 
required to perform an F2-based EMS screen, as this method requires the two X 
chromosomes from females for successful MARCM.  FRT19A P0 males were fed 
EMS to randomly induce mutations throughout the germline and subsequently 
crossed to X-balanced virgin females.  Independent mutant stocks were 
generated when single F1 virgin females harboring EMS mutations were crossed 
to X-balanced hemizygous males.  Virgins from the resulting individual mutant F2 
stocks were crossed to “tester” males containing all required genetic elements to 
induce MARCM clones within the wing.  F3 MARCM females were then assayed 
for suppression of WD. 
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 To screen autosomes, we performed a faster, F1-based EMS mutagenesis 
screen.  In this screen P0 males containing FRT sites corresponding to the 
chromosome arm of interest were fed EMS and then crossed to “tester” virgin 
females.  Rather than generating independent mutant stocks, wings from F1 
MARCM males were immediately assayed for WD defects.  Mutant F1 males 
displaying the correct phenotype were then crossed back to autosomal balanced 
virgin females for mutation recovery and validation.  F1 males showing normal 
WD were discarded. 
 At the end of this screen, we analyzed over 40,000 mutant chromosome 
arms, while isolating and recovering 15 alleles of genes causing defective WD 
phenotypes (Table 2.1). Three mutations recovered from the F1-based screen 
were mapped to the left arm of chromosome 3 – one was an allele of dsarm 
(dsarm4314), the other two were alleles for the previously uncharacterized gene 
axed (axed0011, axed2094) (Neukomm et al., 2017).  Eleven of the twelve axon 
death defective alleles isolated in the F2-based X chromosome screen were 
characterized to be alleles of the E3 ubiquitin ligase, hiw (Neukomm et al., 2014).  
The last mutant on the X chromosome, initially described as 345x and later 
identified as pebbled, showed a novel degenerative phenotype as well as a 
partial suppression and delay of WD.  These data show a dual approach pairing 
forward genetic screening with modeling WD in the Drosophila wing results in a 
fast and effective method to identify novel regulators of injury-induced axon 
degeneration.  
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Materials & Methods 
 
Fly Strains 
Flies (D. melanogaster) were kept on standard cornmeal agar supplemented with 
dry yeast at 25°C unless stated otherwise. The following lines were obtained 
from Bloomington Drosophila Stock Center unless otherwise stated: 
X Chromosome: y, w1118, Nrg/FM7c, ElaV-Gal4, hs-FLP, UAS-mCD8::GFP, tub-
GAL80, and FRT19A.  
2nd Chromosome: OK371-Gal4, UAS-mCD8::GFP, FRT40A, FRTG13, tub-
GAL80.  ase-FLP2a and ase-FLP2e ((Neukomm et al., 2014)) 
 3rd Chromosome:  UAS-mCD8::GFP, FRT2A, FRT42B, tub-GAL80.  ase-FLP3a 
and ase-FLP3b ((Neukomm et al., 2014)) 
 
Mutagenesis screen and wing injury 
Mutagenesis was performed as described previously (Neukomm et al., 2017). In 
brief, males were starved for 12 hours before consuming mutagen (25 mM ethyl 
methane sulphonate (EMS, Sigma) in 1% sucrose). Males were transferred in 
fresh vials for 12 hours prior to breeding to clean off residual EMS. Wing injury 
was performed as described previously (Neukomm et al., 2014). Wings were cut 
with MicroPoint Scissors (EMS, VANNAS Scissors; #72933–04) and mounted on 
a microscope slide in Halocarbon Oil 27 (Sigma, H8773) and covered with a 
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coverslip.  Mounted samples were immediately used for imaging on a Zeiss 
spinning disc confocal microscope (Intelligent Imaging Innovations, Denver, CO). 
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Figures & Tables 
 
 
Figure 2.1 Modeling Wallerian Degeneration in the Adult Wing. 
(A) Diagram of uninjured adult wing containing GFP+ neurons within the L1 vein. 
Black dashed line represents injury site. Red dashed box indicates axon bundle 
imaging field of view, enlarged below.  5 representative GFP+ axons are pictured 
with their corresponding cell bodies (cb) indicated in upper right corner.  (B) 
Injured wing 7 days post axotomy.  Enlarged insets represent two degenerative 
phenotypes: normal degeneration having equal number of axons and cb (3:3), or 
defective degeneration showing a surplus of axons as compared to uninjured cb 
(5:3).  
 
Figure adapted from Neukomm and Burdett et al., 2017, Neuron, no permission 
required. 
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Figure 2.2. Schematic of F1 and F2 genetic screens using the Drosophila 
wing.   
X chromosome F2-based screen: individual mutagenized FRT19A males (P0) are 
first crossed to X chromosome balanced (lethal gene xxx/FM7c) virgins.  The 
next generation heterozygous F1 mutant (mut*) virgins are crossed to 
hemizygous balancer (FM7c/y) males to establish individual mutant stocks.  F2 
virgins from individual mutant stocks are crossed to wing axotomy tester males.  
F3 female progeny will contain homozygous mutant MARCM clones in wing 
sensory neurons and will be assayed for axon death defective phenotypes. 
Autosomal F1-based screen: mutagenized P0 males are crossed into wing 
axotomy tester virgins. F1 mutant males will contain homozygous mutant 
MARCM clones in wing sensory neurons and will be assayed for axon death 
defective phenotypes. 
   
Figure and images adapted from Neukomm et al., PNAS, 2014, no permission 
required. 
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Table 2.1. Total Chromosome Arms Screened 
 
Chromosome 
Arm X 2L 2R 3L 3R Total 
Number 
Screened 2,045 15,959 7,286 7,647 7,383 40,320 
Recovered 
Alleles 12 0 0 3 0 15 
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Table 2.2.  List of Genotypes Used in Wing Screen 
 
X Chromosome 
FRT19A 
Nrg/FM7c 
tub-GAL80, hs-FLP, FRT19A ; ok371-GAL4,UAS-mCD8::GFP,aseFLP2a/ CyO ; UAS-mCD8::GFP,aseFLP3b/TM3, Sb, e 
Chromosome 2L 
w1118 ; FRT40A, FRTG13/CyO  
ElaV-GAL4, UAS-mCD8::GFP ; tub-GAL80, FRT40A ; UAS-mCD8::GFP, aseFLP3a 
Chromosome 2R 
w1118 ; FRT40A, FRTG13/CyO  
ElaV-GAL4, UAS-mCD8::GFP ; FRTG13, tub-GAL80; UAS-mCD8::GFP, aseFLP3b 
Chromosome 3L 
w1118 ; ; FRT2A, FRT82B 
w1118 ; ok371-GAL4,UAS-mCD8::GFP,aseFLP2e/ CyO ; tub-GAL80, FRT2A 
Chromosome 3R 
w1118 ; ; FRT2A, FRT82B 
w1118 ; ok371-GAL4,UAS-mCD8::GFP,aseFLP2e/ CyO ; FRT82B, tub-GAL80 
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CHAPTER III: The Transcription Factor Pebbled/RREB1 Regulates 
Injury-Induced Axon Degeneration 
 
The following chapter is a preliminary author’s manuscript submitted to the 
scientific journal, Proceedings of the National Academy of Sciences, and was 
under revision at the time this dissertation was written.  All supplemental figures 
have been incorporated into this thesis, therefore, figures have been renumbered 
and reformatted. This text in this chapter may change per required edits and will 
appear under following title:   
The transcription factor Pebbled/RREB1 regulates injury-induced axon 
degeneration.  
Farley JE*, Burdett TC*, Barria R, Neukomm LJ, Kenna KP, Landers JE, 
Freeman MR 
* these authors contributed equally to this work 
 
This work was conducted in the laboratory of Marc Freeman at the University of 
Massachusetts Medical School.  I performed the forward genetic screen, 
alongside Lukas Neukomm, Thomas Burdett, and Elizabeth Allen.  Thomas 
Burdett screened deficiency lines on the X chromosome, initially isolated, 
identified, and performed preliminary characterization on the gene pebbled.  I 
performed all subsequent experiments.  Technical assistance with imaging was 
provided by Romina Barria and Jaeda Coutinho-Budd.  Next generation 
sequencing analysis for ChIP-seq and RNA-seq datasets was done by Kevin 
Kenna in the laboratory of John Landers at the University of Massachusetts 
Medical School. 
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Introduction 
 
Neurons are connected over long distances by their axons, which can extend 
over more than a meter in humans.  Maintenance of axon integrity is essential for 
sustained neural circuit function since axon breakage can block nervous system 
signal propagation.  Axon loss is a hallmark of nervous system injuries such as 
traumatic brain injury and spinal cord injury (Hagg and Oudega, 2006; Kelley et 
al., 2006; Henninger et al., 2016), is a unifying feature of neurodegenerative 
diseases (Adalbert and Coleman, 2013), and is strongly correlated with functional 
loss in patients (Coleman and Perry, 2002).  However, molecular pathways that 
drive axon loss in any context remain poorly defined.  
Wallerian degeneration (axotomy) serves as a useful model to study basic 
aspects of axon biology, and to identify axon death signaling molecules.  
Severed axons, after a defined latent phase, undergo explosive fragmentation 
and are ultimately cleared by surrounding phagocytes (Waller, 1850; Saxena and 
Caroni, 2007; Conforti et al., 2014). The discovery of the slow Wallerian 
degeneration (WldS) mutant mouse, where severed distal axons survived for 
weeks after axotomy, radically changed our view of axonal biology after injury 
from a passive wasting away to an active destruction process (Lunn et al., 1989).  
The observed long-term survival of axon fibers in WldS animals demonstrated 
that axon degeneration is a controlled process, and that under some conditions, 
axons could survive for weeks without a cell body (Glass et al., 1993; Mack et al., 
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2001; MacDonald et al., 2006; Martin et al., 2010).  How this happens remains a 
mystery, but the observation suggested that axons don’t simply waste away due 
to a lack of nutrients.  Indeed, a growing number of studies in a diversity of 
species support the notion that the competence to undergo degeneration is likely 
a genetically programmed event: in the rock lobster, distal severed axons have 
been found to survive for a year after transection in vivo, and remain capable of 
evoked release at NMJs (Atwood et al., 1989; Parnas et al., 1991); fragments of 
Aplysia axons can survive in vitro for extended periods of time without 
degeneration (Benbassat and Spira, 1994); and in C. elegans, most distal 
severed axons never degenerate (Neumann et al., 2011).  Despite these 
surprising observations, to our knowledge, nothing is known about transcriptional 
mechanisms that regulate the competence of axons to degenerate. 
In axons that do undergo Wallerian degeneration, the execution of 
degeneration is driven by axon death signaling molecules.  Drosophila dSarm 
(sterile α, ARM, and TIR domain protein) was the first endogenous molecule 
shown to actively promote axon death (Osterloh et al., 2012). Sarm1 functions in 
a conserved role in mammals (Osterloh et al., 2012; Gerdts et al., 2013), where it 
has been proposed to act as an NAD+ hydrolase that drives axonal degeneration 
through promoting metabolic catastrophe (Gerdts et al., 2015; Essuman et al., 
2017).  Drosophila dSarm is similarly capable of NAD+ hydrolysis (Essuman et 
al., 2017), but requires signaling downstream through the BTB/BACK domain 
molecule Axundead to execute axon death in vivo (Neukomm et al., 2017).  The 
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E3 ubiquitin ligase Highwire/Phr1 also modulates axon death signaling (Xiong et 
al., 2012; Babetto et al., 2013) through a mechanism that appears to involve 
regulating levels of the NAD+ biosynthetic molecule dNmnat/Nmnat2 (Gilley and 
Coleman, 2010; Xiong et al., 2012).  In both Drosophila and mammals, all 
neurons tested thus far have been strongly protected by loss of function 
mutations in dSarm/Sarm1 (Osterloh et al., 2012; Gerdts et al., 2013; Gilley et 
al., 2015), which suggests that axon death signaling molecules are engaged to 
drive destruction in a wide array of, or perhaps all, neuronal subtypes. 
In this study, we present the identification and characterization of a novel 
role for Pebbled (peb), a transcription factor, in axon degeneration.  Peb 
mutations were identified in a forward genetic screen for mutants that 
suppressed Wallerian degeneration.  peb mutants show two predominant axon 
death defective phenotypes:  1) severed distal axons are fully preserved 
morphologically, or 2) the axon shaft breaks into large fragments (partially 
fragmented axons, PFAs) that fail to disintegrate further, lingering in the nervous 
system for weeks.  The PFA phenotype in peb mutants is not observed in control 
or axon death mutants (dsarm, axed, or hiw), and therefore define a new 
genetically accessible step in axon death signaling.  Surprisingly, while PFAs 
form in all tested neurons, the ability of peb mutations to completely suppress 
axon degeneration was only observed in glutamatergic neurons, and not in 
cholinergic neurons, arguing that Peb functions to differentially modulate 
competence to undergo axon degeneration in distinct subsets of neurons.   
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Results 
 
Isolation of a new mutant that suppresses Wallerian degeneration 
To identify novel endogenous regulators of Wallerian degeneration (WD), we 
performed an X chromosome-based F2 forward genetic screen in glutamatergic 
sensory neurons in the adult Drosophila wing using mosaic analysis using a 
repressible cell marker (MARCM) (Neukomm et al., 2014).   Flies were bred to 
generate neuronal MARCM clones using the OK371-GAL4 driver, and axons 
were severed by surgical removal of the distal half of the wing with 
microdissection scissors. Animals were aged for 7 days post axotomy (dpa), after 
which wings were dissected from the animal and axon death was quantified and 
imaged the proximal wing vein.  Neurons with cell bodies that were proximal to 
the injury site remained healthy and uninjured, and served as internal controls, 
represented by ‘cb’ in the upper right corner of each figure panel. 
In control wings, injured axons typically undergo fragmentation by 12 
hours post axotomy (hpa), degenerate fully by 24 hpa, and are cleared by 
surrounding glia after 5 dpa (Neukomm et al., 2014).  We screened ~2000 
independent X-chromosome mutant stocks, and identified one, 345x, that 
exhibited suppression of Wallerian degeneration (Figure 3.1A). While uninjured 
345x mutant axons were similar in morphology to control, 60% of injured axons in 
345x mutants remained partially or fully preserved at 7dpa compared to 0% in 
wild type control: 22% of severed 345x mutant axons remained morphologically 
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intact, while 38% initiated fragmentation, but were maintained in a partially 
fragmented state (PFAs, partially fragmented axons) (Figure 3.1B).  We defined 
PFAs as GFP+ axon fragments that spanned the imaging field of view, and were 
aligned linearly such that they appeared to represent the remnants of a 
previously intact axon.  We rarely observed PFAs in control animals, and only 
early in the phase of axon degeneration (Figure 3.1D), but never in dsarm, 
axundead, or highwire mutants (Osterloh et al., 2012; Xiong et al., 2012; 
Neukomm et al., 2017). Therefore, 345x mutations result in a novel axon death 
phenotype, apparently specific to the execution phase of axonal destruction.  
345x mutants were homozygous lethal, suggesting the affected gene is an 
essential gene.  MARCM clones in uninjured glutamatergic neurons exhibited no 
overt changes in axon morphology, axonal mitochondrial size, and they showed 
no signs of spontaneous axon degeneration for at least 2 weeks after eclosion.   
To distinguish PFAs from normal cellular debris produced by degenerating 
axons, we measured the length of all GFP+ axonal membrane debris from both 
control and 345x clones at 7 dpa. The sparse debris in controls averaged 0.9 μm 
in length, while 345x mutant axons fragments averaged 3.0 μm, ranging in size 
from 0.2-25.5 μm in length (Figure 3.1C).  Preserved intact axons and PFAs 
persisted in 345x mutants over time, as severed intact axons and PFAs were 
observed even 14 dpa (Figure 3.1D-E), although at reduced levels.  
While one portion of a severed axon in 345x mutants was fully protected, it 
was plausible that PFAs might be generated at other positions along the axon.  
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To explore this possibility, we scored axon morphological integrity with single 
axon resolution along the entire length of individual severed intact axons in the 
wing vein of 345x mutants (Figure 3.1F-G).  We found that when axons were 
preserved in the proximal wing, 100% of those axons remained morphologically 
intact along their entire length (Figure 3.1H).  We conclude that severed axons in 
345x mutants fall into one of three phenotypic categories: (1) they are 
morphologically preserved along their entire length, (2) they generate PFAs 
along their entire length, or (3) they degenerate and are cleared normally.   
Mitochondrial dysfunction is a hallmark in axon degeneration, and is 
observed after axotomy and in neurodegenerative diseases (Lin and Beal, 2006; 
Knott et al., 2008; Itoh et al., 2013). In WldS-expressing axons, mitochondria 
remain intact after axotomy long after mitochondria in control animals have been 
destroyed (Avery et al., 2012). We therefore examined mitochondrial morphology 
before and after axotomy in control and 345x mutant clones.  Using a GFP 
targeted to mitochondria, we found no significant difference in the average 
mitochondria length in uninjured neurons between control and 345x mutants 
(Figure 3.1I).  Just prior to the explosive fragmentation stage of the distal axon, at 
8 hours after injury, wildtype mitochondria began to decrease in size, with an 
average length of 0.36 μm.  At 8 hpa, mitochondria of 345x mutants were 
significantly longer, with lengths averaging 0.9 μm (Figure 3.1I).  However, when 
we look at injured axons 24 hours after injury, mitochondria in control axon debris 
and severed intact 345x mutant axons were indistinguishable (Figure 3.1J).  
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These data show that 345x mutant mitochondria exhibit a normal, albeit delayed, 
morphological response to axon injury within axon death defective axons.  This 
loss of mitochondria even in 345x mutant axons that are morphologically intact, is 
strikingly different from dsarm null mutant (Figure 3.1I-J) or WldS-expressing 
severed axons (Avery et al., 2012).  Surprisingly, 345x mutations are capable of 
preserving axon integrity despite the loss of mitochondria. 
 
The 345x mutation maps to the C2H2 Zinc Finger transcription factor 
Pebbled/RREB1 
In order to identify the gene affected by the 345x mutation, we backcrossed the 
345x stock over 5 generations to remove background mutations. The early 
lethality associated with the 345x mutation co-segregated with the axon death 
phenotype, supporting the notion that the 345x mutation affects an essential 
gene.  We used whole-genome sequencing to identify novel mutations in the 
345x mutant that remained after 5 generations of backcrossing, confirmed these 
with PCR and genome sequencing, and then compared these to the original 
345x stock before backcrossing.  The only identified mutation that co-segregated 
with the axon death defective phenotype was a mutation in the pebbled (peb) 
gene that resulted in the loss of a splice donor site in exon 2 and generated a 
novel premature stop codon (Figure 3.2A).  In a parallel set of experiments, we 
screened a collection of X chromosome deficiency lines that had been 
recombined onto an FRT chromosome with the MARCM approach.  In total, 
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these deficiencies removed 38.7% of X chromosome genes, and two non-
overlapping deficiency lines led to a suppression of axon death (Table 3.1).  The 
first deficiency uncovered the E3 ubiquitin ligase Highwire, a known axon death 
signaling molecule (Xiong et al., 2012; Babetto et al., 2013).  The second 
overlapped with the genetic region to which we mapped 345x, and included the 
peb gene.  
Peb (RREB1 in mammals) is a conserved transcription factor that contains 
14 C2H2 zinc finger domains (Ming et al., 2013).  In Drosophila embryos, Peb is 
expressed in amnioserosa (AS), anterior and posterior midgut (AM and PM, 
respectively), trachea, and in the peripheral nervous system and imaginal discs 
during later stages (Yip et al., 1997; Wilk et al., 2000; Pickup et al., 2002).  Loss 
of Peb function leads to defects in embryonic germband retraction and dorsal 
closure of the embryonic epidermis, resulting in lethality.  Peb also plays 
important roles in axon guidance in photoreceptor cells in the developing 
Drosophila visual system (Oliva and Sierralta, 2010; Oliva et al., 2015), but roles 
for Peb/RREB1 in axon death have not been previously reported.   We performed 
immunohistochemistry (IHC) of early stage embryos with α-Peb antibodies and 
confirmed that Peb was localized to the AS, and both the AM and PM (Figure 
3.2B) (Yip et al., 1997).  Consistent with our prediction that the 345x mutations 
would lead to a loss of Peb protein product, we found that embryos homozygous 
for 345x lacked α-Peb immunoreactivity (Figure 3.2B).  
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To confirm that the mutation of peb was responsible for the axon death 
phenotype, we assayed axon death in adult wing glutamatergic neurons with a 
second peb allele, pebE8 (Strecker and Yip, 1991).  We found that pebE8 mutant 
clones phenocopied the 345x mutant phenotype, although the phenotype was 
slightly weaker: in pebE8 mutant MARCM clones 12% of severed axons remained 
morphologically intact, and 21% formed PFAs (Figure 3.2C-D).  We next crossed 
a bacterial artificial chromosome (BAC) containing the genomic copy of peb into 
345x mutants, and found that reintroduction of a wild type copy of pebBAC into 
345x mutants completely rescued the axon death phenotypes (i.e. both axon 
degeneration, the production of PFAs, and clearance of axonal debris) to control 
levels (Figure 3.2E-F) Addition of pebBAC had no effect on uninjured axons 
(Figure 3.3).  Furthermore, we found that the pebBAC rescued the lethality of the 
345x mutation.  We conclude that 345x is a novel mutation in the peb gene, and 
henceforth refer to it as peb345x. 
 
Peb is expressed in wing sensory neurons in imaginal discs 
To determine when Peb might act to regulate axon death, we assayed Peb 
expression using the α-Peb antibody.  Wing sensory neurons are derived from 
sensory organ precursors (SOPs) that develop in the wing imaginal disc (Furman 
and Bukharina, 2008).  Peb is known to be expressed in both the eye/antennal 
and wing imaginal discs in SOPs that give rise to neurons at the 3rd instar larval 
stage (Pickup et al., 2002).  We confirmed this expression by performing IHC 
	50	
with α-Peb on imaginal wing discs from animals driving Peb-GAL4 expression of 
membrane-tagged GFP (Figure 3.4A-E). Peb expression was maintained in wing 
disc cells at 36 hours after puparium formation (apf), and colocalized with the 
neuronal marker ElaV (Figure 3.4Aʹ-Eʹ).  Peb expression was maintained in adult 
sensory neurons as evidenced by: 1) strong neuronal expression GFP by Peb-
GAL4 in the wing, colocalized with pan-neuronal expression of Tomato by nSyb-
QF2 (Figure 3.4Aʹʹ-Eʹʹ) and 2) detection of Peb protein in dissected wing veins on 
Western blots probed with α-Peb antibody (Figure 3.4F).  Conversely, Peb 
expression was undetectable in the central nervous system by either α-Peb 
antibody immunostaining (Figure 3.5) or GFP expression by the Peb-GAL4 driver 
(Sweeney et al., 2007; Oliva and Sierralta, 2010).  Visualization of individual 
neurons at mid pupal stages indicated Peb is largely restricted to the nucleus and 
is not detectable in the axoplasm (Figure 3.4G), which is consistent with the 
notion that Peb acts as a transcription factor.  Together these data argue Peb is 
expressed early in SOPs, prior to the expression of markers of post-mitotic 
neurons, and Peb expression is maintained in adult wing sensory neurons.    
 
Human RREB1 can functionally substitute for Pebbled 
To explore how Peb regulates axon death, we drove expression of cDNA 
constructs encoding full-length Peb, truncated Peb containing zinc fingers 1-8 or 
10-14, and the human homolog, RREB1 (Peb, Peb1-8, Peb10-14, and hRREB1, 
respectively) in control and peb345x clones, and quantified axon degeneration 7 
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dpa (Figure 3.6A, Figure 3.3).  Over expression of full length Peb using the 
GAL4/UAS system (and driving expression with the OK371-GAL4 driver) was 
sufficient to completely rescue the blockade of axon degeneration observed in 
peb345x clones: 100% of mutant axons initiated axon fragmentation (Figure 3.6B-
C).  Expression of the C-terminal zinc finger domains 10-14 (in Peb10-14) was 
sufficient to rescue the axon death defect in peb mutants.  In contrast, expression 
of N-terminal Peb1-8 failed to rescue the axon protective phenotype.  This defines 
the key domains essential for Peb function in pro-degenerative signaling, and 
provides additional support for a transcriptional role for Peb, consistent with 
previous work demonstrating that C-terminal domains are required for Peb to 
bind DNA in vitro (Ming et al., 2013).  Expression of the human Peb ortholog, 
Ras-responsive element binding protein 1 (hRREB1), was also sufficient to fully 
rescue the blockade of axon degeneration (Figure 3.6B-C, Figure 3.3), arguing 
that Peb and hRREB1 exhibit similar properties with respect to target gene 
regulation.  However, while the initiation of axon fragmentation was strongly 
rescued, 17% of the GFP+ injured axons persisted as PFAs in peb345x 
background rescued with Peb.  This approximates the percentage of axons that 
form PFAs in peb345x mutant clones expressing a UAS-LacZ control rescue 
construct, and we observed PFAs in peb345x mutants rescued with hRREB1 
expression.  Additionally, expression of either Peb or hRREB1 in control animals 
led to the production of PFAs, which are only ever rarely observed in the earliest 
phase of normal axon degeneration (Figure 3.6B-C).  These data suggest Peb 
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expression levels may need to be fine-tuned for proper rescue of execution of 
axon death and destruction of PFAs, with too much or too little Peb resulting in 
PFA formation.   
 
Peb loss can fully preserve severed axons in glutamatergic, but not 
cholinergic neurons 
There are ~250 sensory neurons in the Drosophila wing that send axonal 
projections to the thoracic ganglion in the CNS (Fang and Bonini, 2012). These 
cells fall into two subsets based on neurotransmitter profiles: cholinergic (~145 
cells labeled by ChAT-GAL4) and glutamatergic neurons (~40 cell labeled by 
vGlut-QF2 or OK371-GAL4) (Figure 3.7A-B) (Neukomm et al., 2014).  Since the 
peb345x mutation was identified and characterized in glutamatergic neurons, we 
wished to determine whether it also regulated axon death signaling in cholinergic 
neurons.  Approximately 23% of severed peb345x glutamatergic clones failed to 
undergo axon degeneration at 7 dpa, and ~40% of severed axons formed PFAs 
(Figure 3.7C-D).  When we assayed cholinergic peb345x clones, we found a 
complete lack of protection from axon degeneration: 100% of all neurons began 
fragmenting (Figure 3.7C-D).  Of severed axons, 19% form PFAs, indicating that 
peb also regulates PFA formation at some level in cholinergic neurons as 
compared to control clones that underwent normal axon death (Figure 3.8).  In 
axotomy assays with the pan-neuronal driver nSyb-GAL4, we observed only 4% 
of severed mutant clones remaining intact, and there was no change in PFAs as 
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compared to peb345x glutamatergic clones. Control pan-neuronal clones had a 
normal degenerative response to injury.  Given that glutamatergic neurons 
represent 20% of the nSyb-GAL4+ cells, we suspected the only cells protected in 
this background by the peb345x mutation were the glutamatergic neurons.  
Indeed, after screening many hundred clones of injured axons where we 
simultaneously labeled cholinergic neurons (with ChAT-GAL4) and glutamatergic 
neurons (with vGlut-QF2), we only found a single severed, intact axon that 
expressed ChAT-GAL4, and it was also positive for vGlut-QF2 and therefore also 
glutamatergic (Figure 3.7E).  The observation that only glutamatergic neurons 
can be fully protected by peb345x mutations, while PFAs appear with equal 
frequency in both cholinergic and glutamatergic neurons, further supports the 
notion that the initiation (i.e. fragmentation) and execution (i.e. full degradation) of 
axons are genetically separable and differentially regulated by Peb levels.  
Moreover, ability of peb mutants to completely block axon death is limited in the 
wing to glutamatergic sensory neurons. 
 
peb mutations do not block dSarm-induced axon death, although dsarm 
mutations can enhance peb mutant phenotypes in axon death 
Activation of Sarm1 signaling potently drives axon death in mammalian and 
Drosophila neurons (Gerdts et al., 2015).  To determine whether Peb acts 
downstream of dSarm, we crossed peb345x mutants into a background expressing 
a gain-of-function version of dSarm (dSarmΔARM) (Neukomm et al., 2017) and 
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assayed for suppression of axon death.  Loss of Peb function was not sufficient 
to block dSarmΔARM-induced axon death (Figure 3.9A-B), arguing that Peb does 
not act genetically downstream of dSarm, and demonstrating that constitutive 
activation of dSarm is sufficient to eliminate the appearance of PFAs.  We next 
sought to determine whether peb mutants exhibited any dominant genetic 
interactions with components of the axon death signaling cascade including 
dsarm (Osterloh et al., 2012), axundead (Neukomm et al., 2017), or highwire 
(Xiong et al., 2012).  We crossed loss of function mutations of dsarm or axed into 
the peb345x background, and found that loss of a single copy of dsarm was 
sufficient to double the number of intact axons in peb345x animals, while loss of a 
single copy of axed had no effect (Figure 3.9C-D, Figure 3.3).  Removal of one 
copy of dsarm or axed in control clones had no effect on axon degeneration 
(Figure 3.8).  In addition to the increase in fully protected axons, loss of one copy 
of dsarm also reduced the number of PFAs in peb345x mutants (Figure 3.9C).  
Reciprocally, we found that overexpression of dSarm in a peb345x background led 
to a partial suppression of the ability of peb345x to fully protect axons, and an 
increase in the number of PFAs. Manipulation of Axed or Hiw had no effect 
(Figure 3.9E-F, Figure 3.3).  Overexpression of dSarm, Axed, and Hiw in control 
clones had no effect on axon degeneration (Figure 3.8).  Thus, the 
neuroprotective effects of peb345x mutants are highly sensitive to dSarm levels, 
with a slight decrease or increase in dSarm levels enhancing or suppressing, 
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respectively, the efficacy of peb mutants to fully block the initiation of axon 
degeneration after axotomy. 
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Discussion 
 
Distal axons separated from their cell bodies can survive in a functionally 
competent state for days to weeks after axotomy in multiple species (Parnas et 
al., 1991; Stengl, 1995; Neukomm et al., 2017).  It therefore seems plausible that 
some axons are programmed to degenerate while others are not.  In this study, 
we identify the transcription factor Pebbled (Peb)/RREB1 as a novel essential 
modulator of axon death in Drosophila.  Through epistatic analysis, we can place 
peb upstream of dSarm or in a separate, parallel pathway which ultimately 
converges on axon death.  The simplest interpretation of our data is that Peb 
regulates axon death signaling in glutamatergic axons at the transcriptional level.  
Human RREB1 can rescue axon death phenotypes associated with loss of peb, 
arguing for strong conservation of the binding properties of Peb and hRREB1, 
and implying that RREB1 may play similar roles in axon biology in mammals.  
Pebbled appears to identify a novel step in the axon death signaling 
cascade.  Loss of Pebbled function resulted in the appearance of three axon 
phenotypes after injury: (1) full morphological preservation with a slightly delayed 
loss of mitochondria; (2) the generation of partially fragmented axons (PFAs) that 
linger in the nervous system for weeks, but which also lose mitochondria after a 
short delay; or (3) apparently normal axon death signaling and clearance.  The 
cell biology of axon preservation in peb mutants is unique, and implies that peb 
mutants identify a new genetically accessible step in axon death signaling.  PFAs 
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have not been observed in other axon death mutants (i.e. dsarm, hiw, or axed), 
as these mutants all fully block axon degeneration after axotomy (Osterloh et al., 
2012; Babetto et al., 2013; Neukomm et al., 2017).  Understanding the nature of 
PFA production compared to normal axon degeneration is an important goal for 
future study.  In the case of dsarm mutants, in addition to the axon shaft 
maintaining integrity, mitochondria also appear well-preserved.  That was not the 
case in peb mutants where mitochondria degenerated after only a short delay, 
and preserved axons were severely depleted of mitochondria for the duration of 
their extended survival.  Interestingly, the phenotype of individual peb mutant 
axons is consistent along the entirety of the axon shaft—we never observed an 
axon that generated PFAs in one portion, but was fully protected elsewhere.  
Unraveling the molecular basis of this all-or-none type of phenotypic expression 
is of great interest for the future.  Finally, while some PFAs are observed in 
control animals immediately after the initiation of axon fragmentation, they quickly 
undergo explosive degeneration and are cleared.  From these data, we conclude 
that Peb functions both at the initial phase of axon breakage into smaller 
fragments, and subsequently during the phase of explosive degeneration.    
 To date all known axon death signaling molecules—dSarm, Hiw, and 
Axed—have been proposed to function locally in the axon to drive destruction, 
and their neuroprotective effects extend to both glutamatergic and cholinergic 
neurons (Osterloh et al., 2012; Xiong et al., 2012; Neukomm et al., 2017).  Based 
on its expression in the nuclei of wing sensory neuron precursors and mature 
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neurons, and the fact it is a C2H2 zinc finger transcription factor, we propose that 
Peb functions at the transcriptional level to help establish and/or maintain 
competence to undergo axon degeneration.  While Peb appears to be expressed 
broadly in wing sensory neurons, surprisingly, the ability of peb mutants to fully 
block axon fragmentation is restricted to glutamatergic neurons.  How Peb 
selectively protects glutamatergic axons is unclear, but could modify axonal 
phenotypes through the JNK signaling cascade.  During embryogenesis, in 
amnioserosa peb mutants show increased levels of AP-1 transcriptional activity 
downstream of the JNK signaling cascade (Reed et al., 2001), which in turn 
inhibits cytoskeletal rearrangements that allow for cell migration (Yip et al., 1997; 
Reed et al., 2001; Scuderi and Letsou, 2005).  We have found a lack of evidence 
to support a role for JNK signaling in axon death (Osterloh et al., 2012; 
Neukomm et al., 2017), but some data support a neuroprotective role for this 
pathway by controlling baseline levels of Nmnat (Walker et al., 2017).  Peb has 
also been shown to negatively regulate nervy, the Drosophila homolog of 
mammalian MTG8 proto-oncogene (Wildonger and Mann, 2005; Ming et al., 
2013); however, we observed no alterations in axon death when we 
overexpressed nervy in glutamatergic neurons. 
 The nuclear localization requirement of the carboxy terminal DNA binding 
zinc finger domains of Peb for rescue suggests that Peb is regulating injury-
induced axon degeneration at the transcriptional level.  We attempted to identify 
direct transcriptional targets of Peb by expressing a tagged version of Peb in the 
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Drosophila embryonic cell line, GM2 (Genetics, Milano 2) (Mosna and Dolfini, 
1972), and performing chromatin immunoprecipitation with antibodies specific to 
tagged Peb and subsequent deep sequencing (ChIP-seq).  This approach 
successfully identified the one known target for Peb, the transcriptional regulator 
Nervy, whose elimination did not block axon death, and several novel new 
potential Peb targets (Table 3.2).  We did not find evidence for direct binding of 
Peb to regions containing known axon death signaling genes (i.e. dsarm, axed, 
or hiw).  This could indicate that Peb does not directly modulate axon death 
genes in vivo to exert its effects, although it remains unclear how similar Peb 
transcriptional activity in GM2 cells might be compared to neurons.    
Our analysis of peb mutant phenotypes reveals new features of the cell 
biology of axon death.  Our discovery of PFAs in peb mutants implies that axon 
degeneration can be genetically dissected into activation and execution phases: 
we propose that PFAs represent an activation, but failure to execute axon death.  
We found that either increased or decreased Peb levels could lead to the 
production of PFAs, arguing that fine-tuning of Peb levels is essential for 
appropriate execution of axon death.  Furthermore, Peb modulation of PFA 
production is not limited to glutamatergic neurons, since we found PFAs in 
cholinergic neurons under both loss- and gain-of-function Peb conditions.  
Interestingly, Peb allows us to genetically separate mitochondrial loss from axon 
degeneration.  We observed mitochondrial degeneration even in fully protected 
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peb mutant axons, indicating that mitochondrial destruction must occur through a 
Peb-independent signaling pathway.  
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Materials & Methods 
 
Fly strains 
Flies (D. melanogaster) were kept on standard cornmeal agar supplemented with 
dry yeast at 25°C unless stated otherwise. The following lines were obtained 
from Bloomington Drosophila Stock Center: y, w1118, FM7cKr-GAL4, GFP, FRT 19A, 
hs-FLP,tub-GAL80,FRT19A, hntE8, ChAT-GAL4, vGlut-QF2, UAS-IVS-
myr::tdTomato, QUAS-mtdTomato-3xHA, UAS-mito-HA-GFP, nSyb-GAL4, 
FRT2A, FRT82B, 5xUAS-mCD8::GFP. OK371-GAL4 (Mahr and Aberle, 2006), 
ase-FLP2a and ase-FLP3e (Neukomm et al., 2014), UAS-hRREB1, UAS-Peb1-8, 
and UAS-Peb10-14 (gift from H. Lipshitz, U of Toronto, Toronto, Canada), 
Pebbled-GAL4 (Sweeney et al., 2007), UAS-nls-LacZ, dSarm896 (Osterloh et al., 
2012), FRT2A, FRT82B, axed0011, UAS-dSarm, and UAS-axed (Neukomm et al., 
2017), UAS-Hiw (Wu, 2005), pebBAC was generated by injection of the bacterial 
artificial chromosome CH321-46J02 (BAC PAC Resources, Children’s Hospital 
Oakland Research Institute) with Phi31-mediated integration into the genomic 
locus attP2 (BestGene).  
 
Transgenic constructs 
UAS-Peb was generated by amplifying peb from cDNA clone GH10905 
(Drosophila Gene Collection, Berkeley Drosophila Genome Project) for cloning 
with Gibson Assembly (New England Biolabs) into the pJFRC5-5XUAS-IVS-
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mCD8::GFP vector (Pfeiffer et al., 2010). UAS-Peb::Myc was generated cloning 
amplified peb cDNA with Gibson Assembly (New England Biolabs) into 
5XUAS::5XMyc,  modified from pJFRC5-5XUAS-IVS-mCD8::GFP. UAS-Nvy was 
generated by subcloning the nvy ORF from cDNA clone LD17501 into the 
pJFRC5-5XUAS-IVS-mCD8::GFP vector. Plasmids were sequenced and injected 
with Phi31-mediated integration into genomic loci attP40 and attP2 (BestGene).  
 
Antibodies 
Mouse anti-pebbled (1G9, Developmental Studies Hybridoma Bank)(IHC 1:25, 
WB 1:50), mouse anti-ElaV (9F8A9, Developmental Studies Hybridoma Bank) 
(1:100), rat anti-ElaV (7E8A10, Developmental Studies Hybridoma Bank) (IHC 
1:100, WB 1:50), mouse anti-tubulin (DM1A, Sigma) (WB 1:5000), goat anti-
mouse IgG H&L Alexa Fluor 488 (ab150117, Abcam) (IHC 1:100), donkey anti-
rat IgG H&L Alexa Fluor 568 (ab175475, Abcam) (IHC 1:100),, donkey anti-
mouse IgG H&L Alexa Fluor 647 (Jackson) (IHC 1:100), sheep HRP anti-mouse 
(ab6080, Abcam), goat HRP anti-rabbit (ab6721, Abcam) (WB 1:5000), goat 
polyclonal to Myc ChIP-grade (Abcam, ab9132), and goat polyclonal IgG 
(Abcam, ab37373). 
 
Mutagenesis screen and wing injury 
Mutagenesis was performed as described previously (Neukomm et al., 2017). In 
brief, males were starved for 12 hours before consuming mutagen (25 mM ethyl 
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methane sulphonate (EMS) in 1% sucrose). Males recovered in fresh vials for 12 
hours prior to breeding. Wing injury was performed as described previously 
(Neukomm et al., 2014). Wings were cut with MicroPoint Scissors (EMS, 
VANNAS Scissors; angled on side, delicate, 5-mm cutting edge, #72933–04) and 
mounted in Halocarbon Oil 27 (Sigma, H8773) on a microscopy slide and 
covered with a coverslip, and immediately used for microscopy.  
 
Immunohistochemistry 
Embryo fixation and staining – Embryos were collected on grape-juice agar 
plates overnight at 25°C and dechorionated for 3 min in 50% sodium 
hypochlorite solution. Dechorionated embryos were washed in PBT buffer (1X 
phosphate buffered saline, 1% bovine serum albumin, 0.1% Triton X-100) and 
fixed for 25 minutes in equal parts Heptane and PEMFA buffer (100 mM PIPES 
(pH 6.9), 2 mM EGTA, 1mM MgSO4, 4% paraformaldehyde). Lower aqueous 
phase was removed and methanol was added. Sample was vortexed for 30 
seconds to remove the vitelline membrane, followed by 3X methanol washing. 
Fixed embryos were washed 5X and blocked in PBT for 30 minutes then 
incubated with primary antibody at 4°C overnight. Embryos were washed 5X in 
PBT and incubated with secondary antibody for 2 hours at room temperature. 
Embryos were washed 5X in PBT and mounted in Vectashield anti-fade 
reagent for imaging. 
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 Larval imaginal wing discs – Wandering third instar larvae were 
collected and imaginal wing discs were dissected as previously described 
(Spratford and Kumar, 2014). Immunohistochemsitry on imaginal wing discs 
was performed as described above. 
Pupal wings –Pupae were staged and collected at 36 hours after 
puparium formation. Animals were dissected as previously described (Classen et 
al., 2008). Immunohistochemsitry on pupal wings was performed as described 
above. 
 
GM2 cell culture 
Drosophila GM2 cells (Drosophila Genomics Resource Center) were maintained 
at 25°C in Hyclone SFX-Insect cell culture medium (GE Healthcare Life 
Sciences) supplemented with 10% Fetal Bovine Serum (Hyclone, GE Healthcare 
Life Sciences) and 1x Penicillin-Streptomycin (Pen Strep) (ThermoFisher 
Scientific).  
 
Western blot 
GM2 cells – cells were collected and lysed in RIPA buffer (10 mM Tris-Cl (pH 
8.0), 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 
mM NaCl) supplemented with protease inhibitor tablet (cOmplete Mini EDTA-
free, Roche). Laemmli buffer (0.1% β-Mercaptoethanol, 0.0005% Bromophenol 
blue, 10% glycerol, 2% sodium dodecyl sulfate, 63 mM Tris-HCl (pH 6.8)) was 
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added to the lysate and incubated at 95°C for 10 minutes. 10 μl samples were 
loaded per lane onto a 4%–12% gradient SDS-PAGE.  
 
Adult wings – approximately 600 w1118 adult wings were removed from the 
animals with MicroPoint scissors and immediately placed in an Eppendorf tube 
on dry ice. Tissue was mechanically homogenized using a BioMasher II tube and 
pestle (Kimble) in 1X Laemmli buffer. Homogenate was incubated at 95°C for 10 
minutes. 10 μl samples were loaded per lane onto a 4%–12% gradient SDS-
PAGE.  
 
ChIP-seq 
Transfection.  1.2 x 107 GM2 cells were plated out in 10 cm plates 24h prior to 
transfection. Cells were transfected with pAc-GAL4 (Addgene) with or without 
UAS-Peb::Myc constructs to a final concentration of 15 mg DNA using Mirus 
TransIT-Insect (Mirus Bio).  Cells were harvested 48h after transfection and used 
for chromatin immunoprecipitation (ChIP) described below.  
ChIP.  Protocol was modified from Atianand et al., 2016 (Atianand et al., 
2016).  Transfected GM2 cells were cross-linked in suspension with 1% 
formaldehyde (Thermo Fisher Scientific) for 10 min at room temperature, and the 
cross-linking was quenched twice with 125 mM Glycine/PBS for 5 min each. 
Cells were pelleted and washed twice with ice-cold PBS.  Nuclear pellets were 
isolated by swelling cross-linked cells in hypotonic lysis buffer (25 mM Hepes pH 
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7.4, 1.5 mM MgCl2, 10 mM KCl, 0.5% NP-40 and 1 mM DTT) supplemented with 
1x cOmplete Mini EDTA-free (Roche) at ice for 15 min, followed by Dounce 
homogenization.  Nuclear pellets were suspended in sonication buffer (50 mM 
Hepes pH 7.4, 140 mM NaCl, 1 mM EDTA, 1% Triton-X 100, 0.1% Sodium 
deoxycholate, 0.5% SDS, 1 mM DTT and 1x protease inhibitor cocktail) and 
incubated at ice for 10 min. Nuclear extracts were sonicated using Bioruptor 
UCD-200 (Diagenode Inc., Sparta, NJ) for 12 cycles of “30 sec ON and 30 sec 
OFF” at the highest voltage setting to generate 200 - 500 bp chromatin 
fragments. In each experiment, chromatin was first processed to confirm DNA 
shearing to 200 - 500 bp fragments by agarose gel electrophoresis, and the DNA 
concentration was measured by fragment analysis.  Equal quantities of sheared 
chromatin (20 µg per IP) was diluted 1:5 in sonication buffer (no SDS) to the final 
volume of 1.5 ml, and immunoprecipitated overnight with 2 µg of target-specific 
antibodies or isotype control IgG antibodies at 4° C, overnight.  The antibodies 
used in ChIP were: anti-Myc ChIP-grade and rabbit polyclonal IgG. Chromatin 
complexes were captured using 20 µl ChIP-grade Protein A/G magnetic beads 
(Thermo Scientific) at 4° C for 1 hr.  Beads were washed once with sonication 
buffer (containing 0.1% SDS), two times with high salt buffer (50 mM Hepes pH 
7.4, 500 mM NaCl, 1 mM EDTA, 1% Triton-X 100, 0.1% Sodium deoxycholate, 
0.1% SDS), two times with LiCl buffer (20 mM Tris pH 7.4, 250 mM LiCl, 1 mM 
EDTA, 0.5% NP-40, 0.1% Sodium deoxycholate, 0.05% Tween-20), and once 
with TE buffer (10 mM Tris pH 7.4, 1 mM EDTA).  Each wash was performed at 
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room temperature for 5 min in 1 ml volume.  Beads were captured using 
DynaMag spin magnet (Thermo Scientific).  Elution was performed by 
suspending beads in 100 µl elution buffer (20 mM Tris pH 7.4, 1% SDS, 50 mM 
NaHCO3, 1 mM EDTA).  ChIP eluates were reverse cross-linked at 650 C for 4 
hr, digested with Proteinase K (10 mg/ml) at 550 C for 1 hr and 2 µl RNase A 
(Invitrogen) at 37° C for 30 min.  ChIP purified DNA was cleaned using PCR 
purification columns (Qiagen) and subjected to fragment analysis for 
concentration and quality for library preparation. 
ChIP-seq analysis.  ChIP library was prepared using NEBNext Ultra II 
DNA Library Prep Kit for Illumina (New England Biolabs, E7645S) paired with 
NEBNext Multiplex Oligos for Illumina, Primer Set 1 (New England Biolabs, 
E7335S) and amplified 8 rounds in a thermocycler.  Sequencing was performed 
using an Illumina HiSeq 2500 genome analyzer (50bp, single end) at the Bauer 
Core Facility at Harvard University. Data were analyzed according to the 
recommended best practices set out by the ENCODE and modENCODE projects 
(Landt et al., 2012). Briefly raw sequencing reads were aligned to build BDGP6 
of the Drosophila reference genome using bwa (Li and Durbin, 2010). Duplicate 
reads were removed using picard (http://broadinstitute.github.io/picard). Peak 
calling was performed using the SPP caller (Kharchenko et al., 2008) as 
implemented in the phantompeakqualtools package 
(https://github.com/kundajelab/phantompeakqualtools). The significance of peak 
calls was assessed using the Irreproducible Discovery Rate (IDR) method (Li et 
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al., 2011; Landt et al., 2012) and code provided by the ENCODE consortium 
(https://sites.google.com/site/anshulkundaje/projects/idr). Annotation of peak 
calls was performed using PAVIS (Huang et al., 2013). 
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Figures & Tables 
 
 
Figure 3.1. Mutation 345x Causes Defective Wallerian Degeneration In Vivo.   
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Figure 3.1. Mutation 345x Causes Defective Wallerian Degeneration In Vivo.  
(A) Glutamatergic clones within the L1 anterior margin vein of the adult wing 
were labeled with mCD8::GFP.  Both uninjured and injured (7 days post 
axotomy, dpa) are shown (scale bar, 10 μM).  Cell bodies (cb) of uninjured 
clones within each wing were counted and indicated in the upper right corner of 
each panel. Mutant 345x exhibited two axon death defective phenotypes: either 
severed intact or partially fragmented axons (PFAs).  (B) Quantification of peb 
mutant phenotype. PFAs (gray) and severed intact axons (black). n > 30 wings.  
(C) Quantification of total continuous GFP+ axon debris length, 7dpa.  (D-E) Time 
course data for both controls and 345x mutants over 14 dpa (n > 30 wings).  (F) 
schematic of the adult wing showing the distal and proximal imaging fields of 
view.  (G-H) confocal image and quantification of severed intact axons were 
imaged and traced down the length of the wing. Asterisks indicate cell bodies of 
uninjured clones (n = 14 wings, 27 severed intact axons).  (I) Mitochondria 
(green) and glutamatergic neurons (red) of control and peb mutant clones 
imaged and measured at various times after axotomy (scale bar, 10 μM).  (J) 
Quantification of mitochondria length in control and peb mutant clones at 8 hpa 
(control: n = 11 wings, 185 measurements. peb: n = 13 wings, 241 
measurements), 1 dpa (control: n = 10 wings, 211 measurements. peb: n = 16 
wings 170 measurements), and 7 dpa (peb: n = 15 wings, 182 measurements). 
2-way ANOVA, error = SEM (**,†† p < 0.01, ***,††† p < 0.001, ****,†††† p < 
0.0001) ). † and * represent PFA and severed intact significance, respectively. 
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Figure 3.2. 345x Encodes the Transcription Factor Pebbled.  (A) The 345x 
mutation lesion was identified as a splice donor variant (shown in blue) within 
exon two of the gene pebbled on the X chromosome.  (B) Immunohistochemistry 
against Pebbled in w1118 control embryos showed localization to the amnioserosa 
(AS) and midgut (anterior AM, posterior PM). Homozygous peb345x mutant 
embryos showed no immunoreactivity with the Peb antibody. Scale bar = 100 
μm.  (C) PebE8 mutant allele phenocopies the axon death defect observed in 
peb345x mutant clones (n>30 wings).  (D) Genomic peb345x is crossed into peb345x 
mutant clones and completely rescued defective axon death back to control 
levels (n > 30 wings). Scale bar = 10 μm. 2-way ANOVA, error = SEM (*,† p < 
0.05, ***,††† p < 0.001, ****,†††† p < 0.0001). † and * represent PFA and 
severed intact significance, respectively. 
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Figure 3.3.  Uninjured Control and peb345x Clones. Representative images of 
uninjured control and peb345x mutant clones with various genetic manipulations. 
Manipulations did not alter axon morphology and did not induce spontaneous 
degeneration in either genotype.  
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Figure 3.4.  Pebbled is Expressed in Neuronal Nuclei Within the Developing 
Wing.    
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Figure 3.4.  Pebbled is Expressed in Neurons Within the Developing Wing.   
(A-Aʹʹ) Immunohistochemistry of imaginal wing discs and wings at different 
stages of development (larva, pupa, and adult), scale bar = 100 μm. Dashed box 
indicates field of view of insets.  (B-Bʹʹ) merged fluorescent image showing (C-Cʹʹ) 
Peb-Gal4 driving expression of UAS-mCD8::GFP (green) was present in most 
sensory organ precursors (SOPs) within the larval wing disc, as well as the 
neurons in the pupal and adult wings.  (D-Dʹʹ) Pebbled (blue) was expressed 
early and remains on during wing development.  Hollow arrowhead indicates 
SOP that expresses Pebbled yet lacks GFP due to differential driver expression.  
(E-Eʹ) the neuronal protein ElaV (red) was expressed later during pupal wing 
development. Solid arrowhead in pupal wings indicates a neuron that expresses 
GFP from the Peb-Gal4 driver, and endogenous Pebbled and ElaV.  (Eʹʹ) The 
presence of the cuticle in adult wings prohibited IHC, therefore neurons were 
examined by the expression pattern of QUAS-myr::tdTomato under the pan-
neuronal driver, nSyb-QF2 (red). While the nSyb-QF2+ expression pattern 
colocalizes with the Peb-Gal4 expression pattern in the adult wing, fluorescent 
intensity levels vary between neighboring neurons. Asterisk indicates a high 
intensity nSyb-QF2+ neuron next to a high intensity Peb-Gal4+ neuron, indicated 
by an arrow. Scale bar = 10 μm.  (F) Western blot from GM2 cells and adult 
wings. Homogenate from adult wings showed Peb expression continued to 
remain on at high levels after development. ElaV immunoreactive band 
(asterisk).  
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Figure 3.5.  Peb is not detectable in the CNS.  Immunohistochemistry against 
Pebbled (blue) and neuronal nuclear ElaV (red) in third instar larval brains.  (A) 
Single slice low magnification fluorescent image showing Peb is not detectable in 
the CNS.  Scale bar = 100 μm.  Dashed box indicates field of view of inset. (B) 
Enlarged view of ventral nerve cord shows Peb is not detectable in ElaV+ 
neurons within the cortex.  Scale bar = 10 μm.  
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Figure 3.6.  Human RREB1 Functionally Rescues Axon Death Defect in peb 
Mutants.  (A) Schematic of Pebbled protein structure. Full length pebbled 
contains 14 C2H2 zinc finger domains (yellow ovals) clustered along the length of 
the protein. The human homolog of peb, Ras-responsive element binding protein 
1 (hRREB1) is shown.  (B-C) Representative images and quantification of Peb 
and hRREB1 functional rescue in control or peb clones, 7 dpa. Scale bar = 10 
μm. (c) Quantification of axon score, 7 dpa (n > 30 wings). 2-way ANOVA, error = 
SEM (*,† p < 0.05, **,†† p < 0.01, ****,†††† p < 0.0001). † and * represent PFA 
and severed intact significance, respectively. 
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Figure 3.7. Pebbled Axon-Protective Phenotype Observed Only in 
Glutamatergic Neurons.   
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Figure 3.7. Pebbled Axon-Protective Phenotype Observed Only in 
Glutamatergic Neurons.  (A) fluorescent projection image of two neuronal 
subsets within the L1 vein of the adult wing, cholinergic neurons (green) and 
glutamatergic neurons (red). Orthogonal view indicated at asterisk. Scale bar = 
10 μm.  (B) Quantifications of the number of cholinergic and glutamatergic 
neurons in the adult L1 wing vein using ChAT-Gal4 and vGlut-QF2.  (C) 
Representative images of axon death in three different neuronal populations 
(glutamatergic, cholinergic, and pan-neuronal).  (D) Quantification of axon score 
at 7 dpa (n > 30 wings for each genotype. Glutamatergic = 79 injured neurons, 
cholinergic = 211 injured neurons, pan-neuronal = 164 injured neurons).  (E) 
Severed intact peb clone was double labeled with vGlut-QF2 (red) and ChAT-
Gal4 (green). Scale bar = 10 μm.  
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Figure 3.8. Quantifications of Injured Control Clones 7dpa.  (A) Axon 
degeneration quantification of glutamatergic (OK371-Gal4), cholinergic (ChAT-
Gal4), and pan-neuronal (nSyb-Gal4) control clones showed normal axon death 
7dpa (n > 30 wings per genotype).  (B) Axon degeneration quantification of 
control clones lacking one allele of either dsarm or axed showed normal axon 
death 7dpa (n > 30 wings per genotype).  (C) Axon degeneration quantification of 
control clones overexpressing axon death regulators UAS-dSarm, UAS-Axed, 
and UAS-Hiw showed normal axon death 7dpa (n > 30 wings per genotype).   
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Figure 3.9. Pebbled Protective Phenotype is Enhanced When Removing 
One Copy of dSarm.  
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Figure 3.9. Pebbled Protective Phenotype is Enhanced When Removing 
One Copy of dSarm.  (A-B) Overexpression dSarmΔARM, induced Wallerian-
like death in 100% of both uninjured control and peb345x clones, quantified at 2 
days post eclosion (dpe) (n > 15 wings).  (C) Images showing axon death 7dpa in 
control and peb345x clones when one copy of either dsarm or axed was removed. 
Scale bar = 10 μm.  (D) Quantifications of axon score at 7 dpa revealed a 
significant enhancement of severed intact axons in peb345x, dsarm heterozygous 
(n > 30 wings).  (E) Images showing axon death at 7dpa in control and peb345x 
clones while over expressing the pro-axon death genes, dSarm, Axed, or Hiw. 
Scale bar = 10 μm.  (F) Quantifications of axon score at 7 dpa, (n > 30 wings). 2-
way ANOVA, error = SEM (*,† p < 0.05, **,†† p < 0.01, ***,††† p < 0.001, 
****,†††† p < 0.0001). † and * represent PFA and severed intact significance, 
respectively. 
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Table 3.1.  X-chromosome Coverage of Deficiency Lines Tested for Axon 
Death Defects.  
 
Df(1)Exel6221 7699 X:470743..523667 Wild Type
Df(1)ED6396 9052 X:493529..523630 Wild Type
Df(1)G1 34050 X:644873..654238 Wild Type
Df(1)ED6443 9053 X:656023..1026707 Wild Type
Df(1)Exel6223 7700 X:769982..909250 Wild Type
Df(1)ED404 8030 X:934942..1135445 Wild Type
Df(1)Exel6225 7702 X:986063..1134927 Wild Type
Df(1)Exel6226 7703 X:1134227..1322377 Wild Type
Df(1)ED6521 9281 X:1135273..1353976 Wild Type
Df(1)Exel6227 7704 X:1322377..1478819 Wild Type
Df(1)Exel8196 7769 X:1478819..1669248 Wild Type
Df(1)ED6565 9299 X:1894112..2317631 Wild Type
Df(1)ED409 8950 X:2042227..2317631 Wild Type
Df(1)ED6574 9054 X:2184630..2387766 Wild Type
Df(1)ED11354 9345 X:2325942..2517801 Wild Type
Df(1)Exel6230 7705 X:2387572..2545663 Wild Type
Df(1)Exel6231 7706 X:2387754..2469301 Wild Type
Df(1)ED411 8031 X:2469859..2642686 Wild Type
Df(1)ED6579 9518 X:2589210..2642686 Wild Type
Df(1)ED6584 9348 X:2636213..2685435 Wild Type
Df(1)ED6630 8948 X:2685540..3036910 Wild Type
Df(1)Exel6233 7707 X:3372961..3485687 Wild Type
Df(1)ED6712 9169 X:3432535..3789615 Wild Type
Df(1)ED6716 24145 X:3799196..4204584 Wild Type
Df(1)ED6720 9055 X:4204351..4544753 Wild Type
Df(1)ED6727 (*) 8956 X:4325174..4911061 Some Protection
Df(1)Exel6290 7753 X:5364532..5428543 Wild Type
Df(1)Exel6235 7709 X:5516611..5593966 Wild Type
Df(1)ED6802 8949 X:5679980..5965880 Wild Type
Df(1)Exel6236 7710 X:5679987..5770561 Wild Type
Sequence Location Axon Degeneration 
Phenotype
BSC 
Stock #
Deficiency 
Name
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Df(1)Exel6237 7711 X:5770561..5892790 Wild Type
Df(1)ED418 8032 X:5901689..6279401 Wild Type
Df(1)ED6829 8947 X:5901976..6353095 Wild Type
Df(1)Exel6238 7712 X:6068994..6268593 Wild Type
Df(1)Exel6239 7713 X:6344333..6516952 Wild Type
Df(1)Exel6240 7714 X:6543963..6669857 Wild Type
Df(1)ED6878 9625 X:6759293..6862948 Wild Type
Df(1)ED6906 8955 X:7195084..7405806 Wild Type
Df(1)Exel6241 7715 X:8709821..8806576 Wild Type
Df(1)Exel9049 7770 X:9247113..9252165 Wild Type
Df(1)ED6989 9056 X:9686653..10070473 Wild Type
Df(1)ED6991 9216 X:9686653..10211524 Wild Type
Df(1)ED7005 9153 X:10071922..10585431 Excess Fragments
Df(1)ED7010 9057 X:10546870..10629307 Wild Type
Df(1)ED7067 9154 X:11390038..11600997 Wild Type
Df(1)Exel6242 7716 X:11622385..11715783 Wild Type
Df(1)ED7170 8898 X:12752602..13277326 Wild Type
Df(1)ED7165 9058 X:12752602..13138948 Wild Type
Df(1)ED7217 8952 X:13642083..13822321 Excess Fragments
Df(1)ED7225 24146 X:13784406..14322206 Wild Type
Df(1)ED7229 9352 X:14222234..14653944 Excess Fragments
Df(1)ED7261 9218 X:14653809..14839412 Wild Type
Df(1)Exel6248 7719 X:14825993..14923667 Wild Type
Df(1)ED7265 9414 X:14826069..15007907 Wild Type
Df(1)ED7289 (**) 29732 X:15024777..15125750 Strong Protection
Df(1)ED7344 9220 X:15626447..15868141 Excess Fragments
Df(1)ED7355 8899 X:16091487..16278417 Wild Type
Df(1)ED7374 8954 X:16695187..17107632 Wild Type
Df(1)ED13478 29733 X:18085406..18102011 Wild Type
* Uncovers pebbled ; **Uncovers highwire
Sequence Location Axon Degeneration 
Phenotype
Deficiency 
Name
BSC 
Stock #
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Table 3.1. X-chromosome Coverage of Deficiency Lines Tested for Axon 
Death Defects.  Deficiency lines uncovering 38.7% of the X-chromosome were 
screened for defective axon death phenotypes.  Chromosomal deletions with wild 
type axon degeneration are shown in blue, while two deletions, Df(1)ED6727 and 
Df(1)ED7289 with protective phenotypes, are shown in orange.  Df(1)ED6727 
uncovers peb, while Df(1)ED7289 uncovers the known axon death regulator, hiw.  
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Table 3.2.  Top Candidate Genes from ChIP-seq 
X Chromosome Chromosome 2 Chromosome 3 
Gene ID Gene Name Gene ID Gene Name Gene ID Gene Name 
FBtr0071213 Trf4-1-RE FBtr0071610 cv-2-RA FBtr0072610 ebd1-RA 
FBtr0074008 HDAC6-RA FBtr0071775 dve-RA FBtr0075941 CG10960-RC 
FBtr0077250 CG15445-RA FBtr0079747 Hnf4-RA FBtr0078245 CG13252-RA 
FBtr0100375 sdt-RF FBtr0079869 IP3K1-RA FBtr0078329 skd-RC 
FBtr0112753 CG34449-RA FBtr0080260 crol-RD FBtr0078549 CG33169-RA 
FBtr0300577 Trf2-RF FBtr0081006 dl-RB FBtr0078722 Madm-RA 
FBtr0333768 Smr-RG FBtr0081111 tup-RA FBtr0081808 grn-RA 
FBtr0340137 mys-RD FBtr0081159 brat-RB FBtr0082092 Unc-115a-RA 
FBtr0340159 Smox-RB FBtr0081193 ssp3-RA FBtr0082139 CG8500-RA 
FBtr0346134 IP3K2-RH FBtr0086112 Adf1-RB FBtr0083228 Akt1-RC 
 
FBtr0087493 Asx-RA FBtr0083257 tara-RA 
FBtr0088099 shn-RB FBtr0083812 CG31459-RA 
FBtr0088128 CG13204-RA FBtr0084169 Eip93F-RA 
FBtr0091802 CG33798-RA FBtr0089331 Mob2-RD 
FBtr0100298 Dyb-RD FBtr0089717 pnt-RB 
FBtr0113043 CG10492-RB FBtr0091929 snRNA 
FBtr0301538 Rtnl1-RH FBtr0099989 kay-RA 
FBtr0302439 EcR-RG FBtr0113246 Xrp1-RE 
FBtr0302439 EcR-RG FBtr0290232 InR-RD 
FBtr0308815 tun-RC FBtr0300747 CG11984-RH 
FBtr0330611 nvy-RC FBtr0304468 ban-RM 
FBtr0330611 nvy-RC FBtr0305351 CG43143-RD 
FBtr0330611 nvy-RC FBtr0305351 CG43143-RD 
FBtr0330612 nvy-RD FBtr0305912 nudC-RB 
FBtr0332593 CG10543-RE FBtr0306814 Eip75B-RF 
FBtr0337091 CG5953-RD FBtr0307368 CG43373-RC 
FBtr0342655 CG4496-RC FBtr0307976 scny-RH 
FBtr0342796 otp-RG FBtr0309032 CR42839-RB 
FBtr0343282 Sox14-RC FBtr0309838 eIF5B-RE 
FBtr0343483 ITP-RG FBtr0321266 CG5823-RB 
FBtr0344437 Kr-h1-RA FBtr0321285 CG3764-RB 
FBtr0345487 HmgD-RD FBtr0330090 MESR6-RB 
FBtr0345761 CR45355-RA FBtr0332650 nkd-RC 
FBtr0345762 CR45354-RA FBtr0332703 Lmpt-RN 
 
FBtr0332735 fz2-RG 
FBtr0333220 Mkp3-RD 
FBtr0335423 srp-RF 
FBtr0336474 Irk1-RE 
FBtr0339925 app-RT 
FBtr0342875 CR44720-RA 
FBtr0345217 E2f1-RE 
FBtr0345835 CR45393-RA 
FBtr0345835 CR45393-RA 
FBtr0347047 CR45939-RA 
FBtr0347047 CR45939-RA 
 
* known Peb binding target, nvy, highlighted in red 
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Table 3.3. List of Animal Genotypes Used in Figures  
Figure 3.1 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/+  
mut*,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/+  
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-IVS-myr::tdTomato, UAS-mito-HA-GFP,ase-FLP2a/+ ; UAS-
IVS-myr::tdTomato,ase-FLP3b/+  
mut*,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-IVS-myr::tdTomato, UAS-mito-HA-GFP,ase-FLP2a/+ ; 
UAS-IVS-myr::tdTomato,ase-FLP3b/+  
 
Figure 3.2 
y, w1118 
peb345x, FRT19A 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/+  
pebE8,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4, UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-
FLP3b/+ 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4, UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/pebBAC 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4, UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-
FLP3b/pebBAC 
 
Figure 3.3 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/+  
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4, UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-
FLP3b/+ 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4, UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/pebBAC 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4, UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-
FLP3b/pebBAC 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-nls-LacZ/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-nls-LacZ/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; dsarm896,FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; 
dsarm896,FRT2A,FRT82B/UAS-mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; axed0011,FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; 
axed0011,FRT2A,FRT82B/UAS-mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-dSarm/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-dSarm/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Axed/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Axed/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Hiw/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Hiw/UAS-
mCD8::GFP,ase-FLP3b 
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Figure 3.4 
y, w1118 
peb-Gal4/+ ; UAS-mCD8::GFP/QUAS-mtdTomato-3xHA ; nSyb-QF2/+ 
 
Figure 3.5 
 y, w1118 
 
Figure 3.6 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-nls-LacZ/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-nls-LacZ/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Peb/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Peb/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Peb1-8/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Peb1-8/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Peb10-14/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Peb10-14/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-hRREB1/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-hRREB1/UAS-
mCD8::GFP,ase-FLP3b 
 
Figure 3.7 
w ; vGlut-QF2,QUAS-mtdTomato-3xHA,ChAT-Gal4,UAS-mCD8::GFP; +/+ 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/+  
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-
FLP3b/+  
FRT19A/tubGal80,hs-FLP,FRT19A ; ChAT-Gal4,UAS-mCD8::GFP/ase-FLP2a ; UAS-mCD8::GFP,ase-FLP3b/+  
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; ChAT-Gal4,UAS-mCD8::GFP/ase-FLP2a ; UAS-mCD8::GFP,ase-FLP3b/+  
FRT19A/tubGal80,hs-FLP,FRT19A ; UAS-mCD8::GFP,ase-FLP2a/+ ; nSyb-Gal4,UAS-mCD8::GFP,ase-FLP3b/+  
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; UAS-mCD8::GFP,ase-FLP2a/+ ; nSyb-Gal4,UAS-mCD8::GFP,ase-FLP3b/+  
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A; vGlut-QF2,QUAS-mtdTomato-3xHA,ChAT-Gal4,UAS-mCD8::GFP/ase-
FLP2a; UAS-mCD8::GFP,ase-FLP3b/+ 
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Figure 3.8 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-FLP3b/+  
FRT19A/tubGal80,hs-FLP,FRT19A ; ChAT-Gal4,UAS-mCD8::GFP/ase-FLP2a ; UAS-mCD8::GFP,ase-FLP3b/+  
FRT19A/tubGal80,hs-FLP,FRT19A ; UAS-mCD8::GFP,ase-FLP2a/+ ; nSyb-Gal4,UAS-mCD8::GFP,ase-FLP3b/+  
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; dsarm896,FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; axed0011,FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-nls-LacZ/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-dSarm/UAS-mCD8::GFP,ase-
FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Axed/UAS-mCD8::GFP,ase-
FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Hiw/UAS-mCD8::GFP,ase-
FLP3b 
 
Figure 3.9 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/UAS-dSarmΔARM ; UAS-
mCD8::GFP,ase-FLP3b/+ 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/UAS-dSarmΔARM ; UAS-
mCD8::GFP,ase-FLP3b/+ 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; dsarm896,FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; 
dsarm896,FRT2A,FRT82B/UAS-mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; axed0011,FRT2A,FRT82B/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; 
axed0011,FRT2A,FRT82B/UAS-mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-nls-LacZ/UAS-
mCD8::GFP,ase-FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-nls-LacZ/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-dSarm/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-dSarm/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Axed/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Axed/UAS-
mCD8::GFP,ase-FLP3b 
FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Hiw/UAS-mCD8::GFP,ase-
FLP3b 
peb345x,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-Hiw/UAS-
mCD8::GFP,ase-FLP3b 
 
Table 3.1 
Deficiency,FRT19A/tubGal80,hs-FLP,FRT19A ; OK371-Gal4,UAS-mCD8::GFP,ase-FLP2a/+ ; UAS-mCD8::GFP,ase-
FLP3b/+  
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CHAPTER IV: Discussion 
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Summary of Findings 
This thesis investigates the underlying mechanism of Wallerian degeneration and 
identifies key molecules required to execute this axon death signal cascade.  
Using sensory neurons in the Drosophila adult wing to model WD in vivo, I have 
identified and characterized a novel role for a transcription factor known to be 
predominantly required in early embryonic development in regulating axon death 
after injury.  This discovery expands on the current model widely accepted in the 
field of local signaling within the distal axon upon axotomy. 
  
In CHAPTER II, I described the approach taken by myself, along with a 
number of colleagues in the lab, to identify novel genes required to execute the 
death of a distal axon after it has been separated from its respective neuronal 
cell body.  Harnessing the power of an unbiased forward genetic mutagenesis 
screen paired with the sophisticated genetic manipulations capable in 
Drosophila, our hard work yielded a number of mutant alleles displaying defective 
axon degeneration.  Together, at the end of three years, we screened through 
more than 40,000 independently mutated chromosomes and identified fifteen 
alleles showing axons with variable degrees of protection from degeneration: 
eleven were identified as mutations in the E3 ubiquitin ligase, hiw, two were 
independent loss of function alleles in the previously uncharacterized gene, axed, 
one was an allele of dsarm, and the final isolated 345x mutation was an allele of 
the gene, peb. 
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While this screen did in fact result in the discovery of two new components 
of the WD signaling cascade, it was not as fruitful as we had anticipated.  We 
had hopes of identifying a great number of genes allowing us to tease apart a 
complete genetic pathway, however as with any system, there are limitations and 
complications.  Looking at the forward genetic F1 screen, one complication that 
arose was the rate of recovery of the isolated mutants.  Theoretically, one should 
have a 50% chance of recovering the mutation; either it reached the germline or 
the mutation was somatic.  There are other factors that contribute to a decreased 
recovery rate, such as mosaicism or the mutation leading to lethality or sterility of 
the isolated male.  Both Thomas Burdett and myself identified axon degeneration 
defective mutants on chromosome 2L but failed to recover them for validation 
and characterization.   Another limiting factor of the screen is that, while the wing 
is significantly faster than previous models of WD, it is still time consuming and 
labor intensive.  Therefore, we have not fully saturated the Drosophila genome 
while looking for suppressors of axon death.  Finally, axonal transection is a 
severe injury and wanting complete axon survival after injury may be too 
demanding.  Therefore, we must consider new approaches to identify remaining 
axon death regulators, which I will discuss in a later section. 
  
The work described in CHAPTER III focused on the identification and 
further characterization of the mutant peb345x allele, emphasizing its role as the 
first transcription factor involved in the regulation of WD.  Preliminary data 
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showed a partial protection and delay of degeneration in peb mutant 
glutamatergic axons after transection, which can be observed up to two weeks 
after injury, albeit at decreased levels.  Not only do loss of peb neurons display 
defective WD, they also exhibit a striking novel degenerative phenotype which I 
classify as partially fragmented axons (PFAs).  Under normal conditions, severed 
distal axons undergo a catastrophic fragmentation, resulting in small pieces of 
axon debris.  Peb mutant axons, on the other hand, frequently fragment into 
larger, intact pieces, measuring an average three-fold longer than control debris.  
 To confirm that both the axon death defect and PFA phenomenon were 
caused by the loss of function peb345x allele, I performed a series of rescue 
experiments which re-expressed peb at endogenous levels as well as 
overexpressed via the GAL4-UAS binary system.  Peb canonically functions as a 
zinc finger transcription factor essential in regulating a multiple cellular processes 
in the developing embryo (Yip et al., 1997; Reed et al., 2001; Sun and Deng, 
2007), and most recently has been shown to be evolutionarily conserved, as its 
human homolog, Ras-responsive element binding protein 1 (RREB1), can 
functionally substitute for Peb in attenuating the transcription of the gene nervy 
(Ming et al., 2013).  Consistent with these data, ectopic expression of RREB1 in 
peb345x mutants completely rescues the observed axon death defective 
phenotype.  Immunohistochemistry analyses show Peb expression is detectable 
only within the nuclei of sensory neurons of the PNS, and functionally requires 
the carboxy-terminal zinc finger domains 10-14 to implement axon degeneration.  
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These data strongly suggest that Peb is modulating WD at the transcriptional 
level.  Which axon death genes are specifically regulated by Peb remains unclear 
and further research on this topic is required.   
 All of the axon death analyses thus far have be performed in OK371-
GAL4+ glutamatergic neurons.  These cells represent only about 1/6 the total 
population of neurons within the L1 vein of the wing (as quantified by GAL4 
expression) (Fang et al., 2012), while the majority of the remainder appear to be 
cholinergic.  Therefore, I tested whether mutant peb’s axon protective 
characteristic extended to other neuronal subsets present in the wing, similar to 
that of the other WD signaling molecules dsarm, hiw, and axed (Osterloh, 2013; 
Neukomm and Freeman, 2014; Neukomm et al., 2017).  To address this 
question, I injured peb mutants labeled with a GAL4 driver specific for cholinergic 
neurons, choline acetyltransferase-GAL4 (ChAT-GAL4), along with the pan-
neuronal driver synaptobrevin-GAL4 (nSyb-GAL4).  Only loss of function peb 
mutant glutamatergic neurons were protected from axotomy.  This result was 
surprising, as the previously identified WD signaling molecules all regulate axon 
degeneration equally across neuronal subtypes.  peb mutant cholinergic neurons 
either degenerated as normal or presented the PFA phenotype. Severed nSyb-
GAL4 clones showed a level of complete protection 1/6th that of glutamatergic 
neurons, further supporting the idea that peb regulates WD specifically in 
glutamatergic sensory neurons.   
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 Finally, I wanted to see where peb may be operating in the WD signaling 
pathway.  The first tool used was the gain of function molecule, dSarmΔARM, 
which constitutively signals for axon death in the absence of injury.  ΔARM 
mimics active dSarm/Sarm1 signaling and can be partially suppressed by 
overexpression of WldS or completely blocked by loss of downstream axed 
(Gerdts et al., 2013; Neukomm et al., 2017).  Loss of peb, however, is not 
sufficient to suppress ΔARM induced degeneration, suggesting that peb is 
functioning either upstream or in a parallel genetic pathway in WD signaling 
(Figure 4.1).  To further examine where peb may be functioning, I performed a 
number of experiments to see a potential enhancement or suppression of the 
axon death defective phenotype by modulating the levels of either dsarm or 
axed.  Traditionally, epistatic analyses assay the interaction of different genes by 
observing the strength or suppression of a given phenotype for each mutant 
allele, however this was not possible with peb and the other axon death genes. 
The dsarm, hiw, and axed mutant clones show complete inhibition of injury-
induced degeneration, therefore any additive protection that peb may confer 
would be masked by their inherently strong protective natures.  Complete 
protection from degeneration increased two-fold in peb mutants only when 
dsarm, and not axed, levels were reduced (peb-/-, dsarm-/+).   Similarly, there was 
a trend toward suppression of protection with increased dSarm levels (peb-/-, 
UAS-dSarm), but not overexpression of Axed or Hiw.  These data indicate peb 
protection may be dependent on dSarm levels, however, I cannot conclude that 
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they interact genetically, as peb/dsarm trans-heterozygous analysis did not show 
a protective effect.   
 
How is peb Regulating Axon Degeneration? 
As mentioned above, the results from CHAPTER III lead me to believe that peb 
is indeed regulating axon death after injury at the transcriptional level.  Current 
literature shows a number of cellular processes are transcriptionally regulated by 
peb during Drosophila embryogenesis.  For instance, successful dorsal closure 
of the embryo requires the establishment of a high/low JNK signaling boundary 
between the epidermis and the amnioserosa (AS).  This JNK boundary is peb-
dependent, and is formed by the down regulation of JNK signaling within the AS 
through increased transcription of the JNK phosphatase, puc (Reed et al., 2001).  
Mammalian JNK signaling has recently been implicated in WD, as knocking 
down both MKK4 and MKK7 or all three JNK molecules (JNK1/JNK2/JNK3) in 
the MAPK signaling cascade modestly suppress axon death in vitro (Yang et al., 
2015; Walker et al., 2017).  These findings, paired with the fact that peb can 
modulate JNK signaling, suggests a potentially ideal WD mechanism.  The AS 
expression data suggests loss of peb in neurons would, in theory, downregulate 
puc expression, increasing active phosphorylated JNK signaling after injury.  In 
our hands, however, loss of function alleles of the Drosophila homologs of 
MKK4/MKK7 (dMkk4/hemipterous, hep) or JNK (basket, bsk) were insufficient to 
block WD in vivo (Osterloh et al., 2012; Neukomm et al., 2017). In contrast, 
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overexpression of Peb should upregulate puc, but has no axon protective effect 
after injury, further discrediting the involvement of JNK in axotomy in Drosophila.  
 Considering its primary role is gene regulation, it is most likely that peb’s 
protective nature is due to altered transcript levels of WD signaling molecules.  I 
have demonstrated that the peb phenotype can be enhanced by modulating 
levels of dsarm, consequently, I hypothesized that loss of peb in the neurons 
could reduce levels of dSarm or potentially hiw and axed. Through ChIP analysis 
and qPCR validation, Peb has previously been shown to transcriptionally 
attenuate nervy expression through direct binding of Peb to the nvy locus (Ming 
et al., 2013).  Therefore, I performed ChIP-seq in a homologous in vitro system in 
an attempt to find novel Peb binding sites in the genome, cross reference these 
sites to genes known to be involved in WD regulation, and further validate 
candidate genes.  While my ChIP-seq dataset positively identified a known gene 
nvy as a Peb binding site, my analysis did not identify any other known WD 
genes.  There are a few possible interpretations of these data: peb indirectly 
modulates the known axon death genes, or peb directly/indirectly modulates 
axon death genes that have yet to be identified.  Due to limitations in starting 
material and antibody concentration, I opted to perform the ChIP in vitro using 
GM2 cells.  A better execution of the experiment would involve performing the 
ChIP in vivo, in peripheral sensory neurons against endogenous Peb, perhaps 
yielding more physiologically relevant results.  
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 While ChIP-seq would identify where Peb is directly binding and 
potentially regulating, looking at differential gene expression profiles will provide 
greater detail of the transcripts affected by loss of peb.  Described in detail in 
Appendix 1, I performed RNA-seq in GM2 cells in which I decrease peb 
expression via clustered regularly interspaced short palindromic 
repeats/CRISPR-associated (CRISPR/Cas9).  When peb expression was 
reduced, there was no significant changes in the transcript levels of identified WD 
regulators dsarm, hiw, nmnat, and bsk.  Unexpectedly, axed levels in GM2 cells 
were significantly upregulated as compared to controls.  This is surprising, since 
modulating levels of axed in peb mutants showed no enhancement or 
suppression of the peb degeneration defect.  Perhaps removing one copy of 
axed is not enough to enhance protection in peb mutants after axotomy, as these 
neurons already show an increased basal level of Axed protein expression.  
Similar to the limitations mentioned with ChIP-seq, a more accurate list of 
differential gene expression would be derived from peb null sensory neurons 
rather than reduced peb expression in GM2 cells.  
 A large body of published literature, functional domain analysis, and IHC 
analysis strongly suggests peb is acting as a transcription factor in regulating 
WD.  While these data support this most logical hypothesis, I cannot exclude the 
possibility of a non-canonical role for Peb in axon death.  When looking at 
peripheral sensory neurons in the pupal wing, Peb was detectable only within the 
nucleus by IHC.  Our attempts to visualize untagged endogenous dSarm or Axed 
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were also unsuccessful, implying that these molecules exist within the cytoplasm 
of distal axons at extremely low levels.  Even the axon protective molecule WldS 
was detectable within the nucleus by IHC analysis, however it is known that WldS 
protein is present in the cytoplasm as well as the mitochondria (Beirowski et al., 
2009; Avery et al., 2012).  I hypothesize an undetectable level of Peb is present 
in the axoplasm and is required for the execution of axon degeneration.  Further 
experiments would be required to investigate this possibility.  In peb mutant 
clones, one could re-express a version of Peb containing a nuclear export signal, 
directing it to the cytoplasm of the axon, and whether axoplasmic Peb regulates 
axon degeneration after injury.  Alternatively, sequential mutational analysis can 
prevent individual zinc finger domains from binding zinc ions, thus abolishing 
their DNA binding capacity and eliminating the transcriptional regulatory function 
of Peb.  Re-expression of these mutated constructs in peb clones will isolate the 
zinc finger domains found to be both necessary and sufficient for execution of 
WD.   
 An interesting question that remains is when during the life of the neuron 
is peb required to initiate degeneration after injury?  Does peb establish a cellular 
competence for axon death early during development once the neuron is 
differentiated, or is it continuously controlling WD gene transcription in mature, 
adult neurons?  Using a combined approach of IHC and GAL4 expression, I 
show that Peb is present in all differentiated sensory neurons (ElaV+ or nSyb-
GAL4+) within the mid-pupal and adult stage wings, suggesting peb may regulate 
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axon death gene expression early during development.  Use of fluorescently 
labeled neurons by GAL4 expression is informative, but the relative stability of 
the membrane bound GFP protein can be misleading when looking to quantify 
expression levels over time.  It would be ideal to examine levels of Peb in 
neurons at different developmental stages of the wing by IHC, however, I was 
restricted to a specific developmental window, as the formation of the waxy 
cuticle prohibits antibody penetration in late pupal and adult wings. 
 Overexpression of full-length Peb, the human homolog RREB1, and the 
C-terminal zinc fingers 10-14 (Peb10-14) are sufficient to rescue the axon 
protective defect in peb mutant glutamatergic (OK371-GAL4+) neurons.  This 
GAL4 driver turns on expression during late embryogenesis and remains on for 
the duration of the life of the animal (Mahr and Aberle, 2006), therefore to 
address when peb may regulate WD, it would be ideal to temporally restrict 
expression of Peb rescue constructs to the adult.  I attempted to re-express full 
length Peb after development by using a temperature sensitive (TS) version of 
the GAL4 repressor, GAL80TS, but encountered a number of difficulties.  The 
animals containing GAL80TS were raised at a restrictive temperature (18°C) until 
adulthood, then switched to a permissive temperature (29°C) to allow for GAL4 
expression.  This shift to a permissive temperature did not allow for sufficient 
accumulation of GFP in the peb mutant neurons while simultaneously increasing 
background autofluorescence of the wing cuticle itself.  Together these made 
visualization of wing axons near impossible.  Perhaps using the analogous 
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antennal ablation WD model would avoid these complications, however in my 
hands, all peb mutant OR22a-GAL4 clones spontaneously degenerated and may 
suggest that peb expression is essential for the survival of these olfactory 
receptor neurons. 
 
The Partially Fragmenting Axon Phenotype 
One of the more unexpected findings from the mutagenesis screen was the novel 
degeneration phenotype observed in peb345x mutants after injury.  Normally, 
transected axons undergo a stereotypical and complete degenerative process in 
which the distal axon loses morphological integrity and fragments into small, 
membranous pieces (Sievers et al., 2003).  In the case of peb mutants, I found 
the axonal fragments displaying this phenotype are present 7 dpa, and measure 
an average 3 times larger than any residual debris observed in control neurons.  
In some instances, I recorded axon fragments exceeding 30 μm in length.  This 
discovery is exciting, as it may have revealed axon degeneration can be 
separated into two phases: initiation and execution.  The transected axons which 
are completely preserved may have an inhibited initiation of degeneration, 
whereas the PFAs could possibly represent a defect in the execution of 
degeneration – these axons begin to fall apart, but do not go through that 
terminal, explosive fragmentation in WD.  Two underlying questions remain 
unanswered: what specifically is causing these PFAs to appear, and what 
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intrinsic mechanism decides whether a peb mutant will degenerate, be protected, 
or present PFAs after axotomy.  
 One possibility could be a potential defect in calpains, the calcium 
dependent cysteine proteases ultimately responsible for the cytoskeletal 
breakdown during WD.  During the tail-end of the latent phase, intra-axonal Ca2+ 
concentrations rise, causing the cleavage of axonal microtubules and spectrin by 
newly activated calpains (Billger et al., 1988; Johnson et al., 1991).  Suppressing 
calpain function by overexpression of the endogenous calpain inhibitor has been 
shown to modestly protect axons from degenerating after injury in vitro (Yang et 
al., 2013), however, when suppression inevitably fails, these axons degenerate 
as normal, that is, all at once along the length of the distal severed axon.  
Drosophila have four endogenous calpains (Calpain A, B, C, and D) (Friedrich et 
al., 2004), therefore, if peb positively regulates one or more of these calpains, 
then perhaps loss of peb in neurons could lead to defective or inefficient 
cytoskeletal degradation and the PFA phenotype.  
 It would be interesting to understand exactly how the peb mutants 
degenerate after axotomy. Classically, degenerating axons take on a dystrophic, 
blebbed morphology resembling beads on a string, then, as if all at once, the 
axons fragment.  In peb mutants presenting PFAs, it appears that there are 
sporadic sites of breakage forming these long axonal pieces, potentially 
representing focal defects in cytoskeletal integrity.  A similar phenotype is seen in 
C. elegans harboring mutations in β-spectrin.  Animals with defects in axonal 
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cytoskeletal integrity spontaneously fragment into long, continuous pieces 
resembling PFAs found in injured peb clones (Hammarlund et al., 2007).  Live 
imaging could shed light on the nature of PFAs, how they are formed, their 
overall dynamics, and how they are eventually cleared from the animal.  Do peb 
mutants break simultaneously or sequentially along the length of the axon?  
Once broken, do these PFAs further fracture or are they chewed back from their 
respective ends? Additional in depth research paired with differential gene 
analysis may answer some of these questions. 
 
Cell Type Specific Protection in peb Mutants 
Specific vulnerability of regions and neuronal subsets within the brain is a well-
established feature in some neurodegenerative diseases.  Selective loss of 
dopaminergic neurons within the substantia nigra pars compacta is a hallmark of 
Parkinson’s disease (Barzilai and Melamed, 2003), while amyotrophic lateral 
sclerosis progressively affects both upper and lower motor neurons in the CNS 
(Blizzard et al., 2015).  Not just limited to the CNS, neurons in the PNS are prone 
to degenerate in peripheral neuropathies, as seen in diabetes and in some 
cases, after chronic exposure to chemotherapeutic drugs (Coleman and Perry, 
2002; Saxena and Caroni, 2011; Geisler et al., 2016).  In WD, however, there is 
no known report of cell specific vulnerability after axonal transection; all wild-type 
neurons will degenerate after axotomy.  
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 Up until now, we believed that WD signaling molecules were created 
equal, functioning the same in all axons.  Removal of either dsarm, hiw, or axed 
in glutamatergic neurons will protect axons from injury-induced degeneration just 
as robustly as if they were removed from cholinergic neurons (Osterloh et al., 
2012; Neukomm et al., 2014; 2017).  As this was an accepted truth, it was most 
surprising when I observed loss of peb in cholinergic sensory neurons failed to 
confer protection after injury.  While complete suppression of degeneration failed 
in these neurons, they still exhibited PFAs, suggesting the two phenotypes are 
potentially genetically separable.  
 How exactly peb regulates axon death in neurons is still unknown.  As 
mentioned previously, I believe that the abundant amount of literature, in 
conjunction with my results in CHAPTER III, support the notion that peb is 
modulating axon death signaling at the transcriptional level.  Perhaps increased 
expression of Peb during neuronal development could establish a cellular 
competence for axons to degenerate after injury.  This notion of “competence” is 
not unheard of, as it has been observed that some axons in certain lower 
invertebrate species (rock lobster, crickets, sea slugs, and C. elegans) are not 
always genetically programed to die after physical injury and fail to undergo WD 
(Atwood et al., 1989; Parnas et al., 1991; Benbassat and Spira, 1994; Stengl, 
1995; Neumann et al., 2011).  Therefore, peb could be programming both 
glutamatergic and cholinergic neurons to degenerate.  A second redundant 
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pathway specific to cholinergic neurons could compensate for the loss of peb 
function.  
 It would be of great interest and importance to tease apart this complex 
discovery.  While the GM2 cell RNA-seq in appendix 1 could contain a 
substantial amount of information regarding the peb protective phenotype in 
general, a more specific approach would be required to understand the cell type 
specific protection of peb mutants.  If it would be possible to independently 
isolate glutamatergic and cholinergic peb null clones from the adult wing, we 
could perform RNA-seq on each cell population.  A four-way comparison of 
changes in gene expression between cholinergic and glutamatergic neurons, wild 
type and mutant, might highlight novel genes of importance.  
  
How Do Transected Axons Survive? 
The discovery of these intrinsic axon pro-degenerative molecules not only shifted 
seminal views in the axon degeneration field, but also has opened many avenues 
for new research and discoveries in neuron-glial biology.  A puzzling idea still 
requiring further investigation is the notion that these mutant axons persist for 
weeks, or in the case of flies, the lifetime of the animal, without support from their 
respective cell bodies.  In terms of energy production, degenerating axons 
experience massive energy depletions after axotomy (Sasaki et al., 2016; 
Essuman et al., 2017) and mitochondria appear to significantly shrink or fragment 
just prior to loss of axonal membrane integrity.  In the case of severed intact peb 
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mutant axons, mitochondria are significantly smaller, resembling the compact, 
swollen mitochondria in control axons just prior to fragmentation, at 7dpa (Park et 
al., 2013).  Presumably, these mitochondria have diminished capacity for energy 
production, however this is purely speculative.  Interestingly, there is no change 
in mitochondria length in dsarm mutants at 7dpa, potentially explaining why these 
mutants completely avoid degeneration while peb mutants simply offer a delay in 
WD.  Further research is required to fully understand the differences of 
mitochondria length between peb and dsarm mutants, and it would be worth 
investigating if this phenotype was caused by peb itself or genes that regulate 
mitochondrial fission or fusion. 
Not only are axon death defective mutants surviving without nascent protein 
synthesis and support from the cell soma, but they have the capacity to release 
neurotransmitters either spontaneously or by artificial stimulation (Xiong et al., 
2012; Neukomm et al., 2017).  Most likely these surviving axons receive local 
metabolic support from surrounding glial cells.  Mammalian data shows axons 
can take up lactate, pyruvate and other metabolites secreted from 
oligodendroglia, and genetic ablation of the monocarboxylate transporter 1, the 
means by which lactate is transported into the periaxonal space from myelin, 
causes degeneration of adjacent axons (Griffiths et al., 1998; Fünfschilling et al., 
2012; Lee et al., 2012).  Looking forward, we can harness the power of 
Drosophila genetics to identify glial specific genes required for axon support and 
maintenance.  Exploiting the protective nature of the WldS protein, we can 
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prevent axons from degenerating while simultaneously modifying genes 
specifically in glia with RNAi.  Resulting candidate genes can be potentially 
validated with loss of function alleles and maintenance of dsarm, axed, or hiw 
mutants can be evaluated.  
 
Identifying Remaining Axon Death Signaling Molecules 
Looking to the future of the axon death field, there are many questions remaining 
to be answered.  In particular, what are the remaining genes and molecules 
required for axon degeneration signaling?  Recent research has made many 
advancements in filling in the gaps of knowledge, but the picture remains 
incomplete.  We know injury to an axon leads to an activation of dSarm/Sarm1 
while simultaneously blocking the anterograde transport of the pro-survival 
molecule dNmnat/Nmant2 (Gilley and Coleman, 2010; Osterloh et al., 2012; 
Gerdts et al., 2013).  Recent research showed the massive energy depletion in 
distal axons is primarily due to a novel NADase function for the TIR domain in 
active Sarm1 signaling (Essuman et al., 2017), but what specifically functions 
upstream and causes Sarm activation remains to be discovered.  Similarly, the 
discovery of axundead shows multiple pathways of axon degeneration (axotomy, 
NAD+ depletion, gain of function dSarm) converge on Axed to execute 
degeneration, but downstream effectors are still unknown.  
 In moving forward, we have to ask ourselves, what is the best method for 
identifying these unknown WD signaling molecules?  Unbiased mutagenesis 
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screening with axotomy has been fruitful multiple times over in isolating novel 
components of this pathway, however, the abundance of genes has proven to be 
less than we predicted.  When the axotomy screen was first started, we believed 
we would find a plethora of genes and piece by piece, we could assemble a 
complete mechanism for axon death.  It appears that after screening over 40,000 
individual mutant chromosomes, there may be fewer genes required to execute 
degeneration, or perhaps there are redundant pathways, and only few key 
molecules such as dsarm, hiw, and axed can suppress WD completely.  
Continuing this screen until saturation of the genome is reached may further pull 
out WD regulators. 
 Axotomy is an extreme injury, and expecting an axon to survive after 
being cut in half may be asking too much from a neuron.  Therefore, we should 
turn to other ways in which to find WD molecules in vivo, specifically, performing 
suppressor screens of axon death.  We can do this two ways: first, we can 
continue the dSarmΔARM suppressor screen which I initiated and describe in 
Appendix 2, and secondly, we can look for suppressors of NAD+ depletion 
induced cell death.  Overexpression of either gain of function dSarmΔARM or 
dNmnatRNAi causes spontaneous degeneration of both axons and their cell 
bodies and can be suppressed in axed loss of function mutants, serving as a 
proof of concept (Neukomm et al., 2017).  Using EMS mutagenesis methods 
established in CHAPTER II, we can quickly screen for candidates in which 
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neurons do not degenerate when ΔARM is expressed or dNmnat levels are 
knocked down. 
 
Axon Death Molecules and Neurodegeneration Therapeutics 
Understanding the underlying molecules governing injury-induced axon 
degeneration goes beyond furthering scientific knowledge in basic axon biology, 
but can ultimately serve a greater purpose in the treatment and prevention of 
devastating neurodegenerative diseases.  Premature axon loss preceding 
neuronal cell death is a prevalent feature observed in a number of nervous 
system diseases and disorders (Stoll and Müller, 1999; Adalbert and Coleman, 
2013; Geisler et al., 2016) as well as chronic injury (Kelley et al., 2006; 
Henninger et al., 2016).  The loss of synaptic terminals and retrograde axonal 
die-back is observed in mammalian models of Alzheimer’s disease, Parkinson’s 
disease, and Huntington’s disease (Li et al., 2001; Scheff et al., 2006; Tagliaferro 
and Burke, 2016).  As it is known that WldS or Sarm1 mutant mice can prevent 
axon death from injury, it is no wonder it they are appealing therapeutic 
candidates for these neurodegenerative diseases.  If it is possible to prevent the 
early loss of the axon, then perhaps it can prevent or delay the future loss of the 
neuron itself, leading to a better quality of life for the affected individuals.     
 WldS mutant mice demonstrate moderate to robust protection from 
diseases such as peripheral neuropathy, progressive motor neuronopathy, and 
glaucoma (Ferri et al., 2003; Coleman, 2005; Beirowski et al., 2008), however it 
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is not an endogenous protein, therefore not a viable therapeutic target.  Overall, 
current research evaluating the efficacy of Sarm1 mutant mice in preventing 
various models of neurodegenerative disease draws one conclusion: Sarm1 
robustly protects axons from degenerating in context of acute disease or injury, 
such as physical injury, diabetes, and chemotherapeutic induced peripheral 
neuropathies (Geisler et al., 2016; Henninger et al., 2016; Turkiew et al., 2017), 
however Sarm1 offers little protection from chronic, progressive diseases such as 
Alzheimer’s disease, Parkinson’s Disease, and Huntington’s Disease (personal 
communication of preliminary data, Dr. Owen Peters). 
 With the new discovery of peb in regulating axon degeneration, I’ve 
increased the pool of possible therapeutic candidate genes, however, peb 
already has two strikes against it.  Firstly, considering peb’s only reported 
function is regulating gene transcription, any small molecule agonist or 
antagonist specific for Peb could have massive adverse effects on unknown 
downstream genes and subsequent biological processes.  Any forward 
advancements in therapeutic targeting would require the identification of all 
genes modified by peb and their respective functional outcomes.  Secondly, Peb 
only partially suppresses and delays axon degeneration after injury, in vivo, in 
Drosophila.  In collaboration with members of the Tessier-Lavigne lab, 
knockdown of RREB1 in murine DRG did not suppress axon degeneration after 
axotomy (personal communication), however the efficacy of the knockdown was 
not tested, therefore we cannot completely exclude the role of RREB1 in WD.  
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Thus, it is not logical to target a gene which doesn’t completely suppress axon 
degeneration and whose function may not be evolutionarily conserved.   
A better molecule to target therapeutically would be Axed, as it is currently 
placed furthest downstream in the injury response signaling cascade, and is 
capable of completely inhibiting multiple pathways of axon death.  While current 
research is exploring the functional conservation of axed from flies to mammals, 
preliminary in vitro data shows promising potential.  Further research is critical to 
understand how axed is functioning as well as to determine whether axed 
mutants succeed in preventing the progressive axon loss in various 
neurodegenerative disease models, where Sarm1 mutants have failed.  Overall, 
targeting WD signaling molecules can lead to breakthrough treatments and 
increasing the quality of life in patients experiencing these devastating diseases. 
 
Conclusion 
The work presented in this thesis described the discovery and characterization of 
a novel role for the C2H2 zinc finger transcription factor, Pebbled, in regulating 
axon degeneration after injury in Drosophila.  I have demonstrated that the 
peb345x loss of function allele isolated from an unbiased forward genetic screen 
significantly suppresses and delays WD, and presents a novel degenerative 
phenotype of partially fragmenting axons. The nuclear localization and functional 
analyses of the various zinc finger domains suggest Peb is functioning 
canonically as a transcriptional regulator, potentially modulating expression of 
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other molecules involved in the WD signaling cascade.  peb mutants also show a 
specificity for blocking axon degeneration only within glutamatergic neurons, as 
cholinergic neurons degenerate as normal.  Finally, genetically modulating the 
expression levels of known pro-degenerative molecules indicate that the axon 
protective phenotype in peb mutants is sensitive to levels of dsarm.  Together, 
these data expand the current model of axotomy-induced degeneration, drawing 
our attention away from local mechanisms within the distal severed axon and 
towards the cell body, to include transcriptional regulation of genes in the 
nucleus.  
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Figures 
 
Figure 4.1. Expanded Model of Wallerian Degeneration Signaling. 
Schematic describing a proposed, modified model of intra-axonal signaling after 
injury to include Peb with pro-degenerative molecules (red) and protective 
molecules (green).  (1) Within glutamatergic neurons, the nuclear localized 
transcription factor Peb can either positively or negatively regulate an unknown 
gene (Gene X, orange) required for axon degeneration which will function 
upstream of dsarm in a parallel genetic pathway.  (2) Peb can negatively regulate 
levels of the pro-degenerative molecule dSarm, effectively decreasing levels in 
the axon.  (3) Peb can have a non-canonical role in regulating axon degeneration 
by acting locally in the axoplasm of the distal axon.  
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Appendices 
 
This work was conducted in the laboratory of Marc Freeman at the University of 
Massachusetts Medical School. 
 
Appendix I: I performed all work with assistance in RNA isolation and library 
preparation from Pei-Hsuan (Xuan) Wu in the lab of Phil Zamore.  Next 
generation sequencing analysis of the RNA-seq dataset was done by Kevin 
Kenna in the laboratory of John Landers. 
 
Appendix II: I performed the forward genetic suppressor screen with assistance 
from Elizabeth Allen. 
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Appendix I:  Differential Gene Expression in CRISPR Knockout  
of pebbled in vitro  
 
Pebbled encodes a zinc finger transcription factor and has been shown to 
negatively regulate genes in vivo (Ming et al., 2013; Oliva et al., 2015).  I have 
shown that loss of function peb mutants have defects in injury-induced axon 
death.  To identify how peb is regulating WD, I wanted to check the differential 
gene expression profiles in cells lacking peb as compared to controls. In order to 
approach this question, I needed to find a system in which I could isolate a 
substantial number of cells with decreased levels of Peb protein.  Peb is an 
essential gene, and homozygous animals do not survive past early embryo 
development, therefore analyzing homozygous loss of function mutant animals 
was not a possibility.  The entirety of my analyses has been done by generating 
mosaic clones in heterozygous animals, so using these animals may not show a 
significant change in peb expression levels.  To avoid these complications, I used 
a homologous in vitro system of embryonic Drosophila cells that endogenously 
express Peb, GM2 cells.  While Schneider 2 (S2) cells are the most common 
Drosophila cells used in culture, Peb is not detectable by western blot analysis. 
 I used the CRISPR/Cas9 gene editing technology to significantly decrease 
expression of peb in vitro (Figure A1.1).  From these cells, along with controls, I 
isolated RNA transcripts and generated triplicate libraries for Illumina deep 
sequencing analysis.  Similar to the ChIP-seq data, nervy is present in the 
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dataset acting as a positive control, as its levels are upregulated when peb is 
decreased, implying the data from this analysis is promising.  An analysis of this 
list shows no significant expression changes in most genes involved in the known 
axon death pathway (dsarm, hiw, nmnat) however axed does appear to be 
significantly upregulated (2.67-fold increase) when peb expression is decreased 
in GM2 cells. These data are interesting since there was no enhancement or 
suppression of degeneration when axed levels were altered, however, it must be 
noted that these data are not from peb mutant neurons, but embryonically 
derived cells with 80% reduction in Peb levels.  This dataset may contribute to 
future investigations of peb’s role in injury-induced axon degeneration, however, 
due to time constraints, I am unable to follow up on validation of potential genes.  
The differential gene expression dataset is too large to be placed in this 
dissertation, but the entire Excel spreadsheet can be viewed through 
LabArchives.com under the DOI:10.6070/H4X928S9 
(https://doi.org/10.6070/H4X928S9). 
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Figure A1.1.  CRISPR Knockout of peb in GM2 Cells.  Immunoblot from GM2 
cells using CRISPR/Cas9 to knockout endogenous peb (pebgRNA lane) after 2 
weeks of puromycin selection.  Cell line did not undergo clonal selection, 
therefore does not show complete loss of Peb protein.  Quantifications show an 
80% reduction in overall Peb protein as compared to controls after 2 weeks of 
puromycin selection. error = SEM, **** = p<.0001, unpaired two-tailed t-test. 
 
 
 
Materials & Methods 
 
Plasmids 
gRNA sequence targeting the 5ʹ end of the peb open reading frame (5ʹ-
GTTGTTGTGCTGTTGCTGTGCGG, determined by flyCRISPR Optimal Target 
Finder) (Gratz et al., 2014) was subcloned into the pAc-sgRNA-Cas9, a gift from 
Ji-Long Liu (Addgene plasmid # 49330), for use with transfections. 
 
Transfection and Cell Selection 
1.2 x 107 GM2 cells were plated out in 10 cm plates 24h prior to transfection. 
Cells were transfected with either pAc-pebgRNA-Cas9 or empty pAc-sgRNA-Cas9 
constructs to a final concentration of 15 mg DNA using Mirus TransIT-Insect 
(Mirus Bio). Transfected cells underwent puromycin selection (Sigma) diluted to a 
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final concentration of 5 μg/mL in Hyclone SFX-Insect cell culture medium (GE 
Healthcare Life Sciences) supplemented with 10% Fetal Bovine Serum (Hyclone, 
GE Healthcare Life Sciences) and 1x Penicillin-Streptomycin (Pen Strep) 
(ThermoFisher Scientific) for 14 days.  Cells were collected 14 days after 
selection for western blot and RNA-seq analysis. 
 
Western blot 
Cells were collected and lysed in RIPA buffer (10 mM Tris-Cl (pH 8.0), 1 mM 
EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl) 
supplemented with protease inhibitor tablet (cOmplete Mini EDTA-free, Roche). 
Laemmli buffer (0.1% β-Mercaptoethanol, 0.0005% Bromophenol blue, 10% 
glycerol, 2% sodium dodecyl sulfate, 63 mM Tris-HCl (pH 6.8)) was added to the 
lysate and incubated at 95°C for 10 minutes. 10 μl samples were loaded per lane 
onto a 4%–12% gradient SDS-PAGE.  Membrane was probed with mouse anti-
pebbled (1G9, Developmental Studies Hybridoma Bank) (1:50), mouse anti-
tubulin (DM1A, Sigma) (1:5000), sheep HRP anti-mouse (ab6080, Abcam), goat 
HRP anti-rabbit (ab6721, Abcam) (WB 1:5000).  Desitometric analysis performed 
using ImageJ. 
 
RNA-seq 
RNA was extracted from 3.0 x 106 cells and 2 μg RNA was used in cDNA library 
preparation as described in (Zhang et al., 2012).  Sequencing was performed 
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using an Illumina HiSeq 2500 genome analyzer (125bp, paired end) at the Bauer 
Core Facility at Harvard University. Raw sequencing reads were aligned to build 
BDGP6 of the Drosophila reference genome using hisat2 (Kim et al., 2015), with 
known splice sites defined as per Ensembl release 89 (Yates et al., 2016). Read 
counts per transcript were generated using HTSeq (Anders et al., 2015). All 
downstream analyses of HTSeq read counts were performed using DESeq2 as 
per recommended guidelines (Love et al., 2014). Differential expression analyses 
included modelling of read counts with respect to both sample batch (replicate 
number) and sample phenotype. Transcripts were only considered where the 
observed read count exceeded a minimum threshold of 3. 
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Appendix II:  Gain of Function dSarmΔARM Suppressor Screen 
 
Similar to the forward genetic axotomy screen described in CHAPTER II, I also 
performed a large-scale EMS mutagenesis suppressor screen during the first 
three and a half years of my graduate career.  In this screen, I utilized the gain of 
function dSarmΔARM (ΔARM) to induce Wallerian-like degeneration 
(degeneration that is suppressible by the protective molecule, WldS) in 
glutamatergic sensory neurons within the adult wing.  Recent literature from 
mammalian data suggests endogenous dSarm/Sarm1 is believed to signal for 
axon destruction upon injury in the following manner:  Axon injury induces a 
conformational change in Sarm through an unknown mechanism, relieving the 
auto-inhibitory N-terminal ARM domain.  This disinhibition allows the TIR 
domains of homodimerized Sarm molecules to signal for axon degeneration 
(Gerdts et al., 2013; 2015). By removing the ARM domain, we have generated 
constitutively active ΔARM molecule, signaling for degeneration in the absence 
of injury (Figure A2.1A) (Neukomm et al., 2017).  As proof of concept, expression 
of ΔARM in wildtype glutamatergic clones within the wing induces neuron 
degeneration in the absence of injury.  Co-expression of WldS in a ΔARM 
background confers axon protection, but does not spare the cell body from 
degeneration, suggesting ΔARM does in fact signal Wallerian-like degeneration 
(Figure A2.1B).   
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Figure A2.1.  Gain of function dSarmΔARM induces Wallerian-like 
degeneration in the absence of injury.  (A) Signaling mechanism of both 
endogenous dSarm/Sarm1 and dSarmΔARM (ΔARM) in degeneration.  (B) 
Representative images of glutamatergic clones in the wing undergo cellular 
degeneration when ΔARM is expressed. Co-expression of the protective WldS 
prevents axon but not cell body degeneration.  Scale bar = 10 μm. 
 
  
Execution of the ΔARM F1 suppressor screen is similar to that of the 
axotomy screen, where chromosome specific FRT males are fed the chemical 
mutagen EMS and crossed to tester virgins containing the correct genetic 
elements for expressing ΔARM in glutamatergic neuron clones in the wing.  In 
the ΔARM screen however, wings from F1 males to be screened are not injured, 
just aged to allow for accumulation of membrane tethered GFP expression.  
Wings are removed from the animals and mounted 5-7 days post eclosion.  
Positive hits identified from the screen would have axons and or cell bodies 
present in wing, suggesting suppression of ΔARM induced axon degeneration, 
would be re-crossed to balancer virgins for mutation isolation and phenotype 
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validation.  From this screen, I initially identified 5 potential suppressors of gain 
of function ΔARM: four on the left arm of chromosome 2 (2L) and one on the 
right arm of chromosome 3 (3R) (Figure A2.2).  The primary phenotypes of the 
mutants ranged from protection of both cell bodies and axons (2L.1, 2L.2, 3R.1) 
to just cell body protection (2L.3, 2L.4).  After isolation of each hit, re-validation 
of all five mutants failed to suppress ΔARM activity. 
 
Figure A2.2.  Primary hits identified from suppressor screen.  Five hits 
identified as potential suppressors of ΔARM induced degeneration demonstrate 
protection of the axon, cell body, or both.  Four mutations were on chromosome 
2L and one mutation on chromosome 3R.  Scale bar = 10 μm. 
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	122	
 There are a few possible explanations for the failure of the re-isolated 
mutants to suppress ΔARM signaling. First, since this was a mosaic screen, the 
mutation may be somatic and not in the germline, resulting in a failure to be 
transmitted to subsequent generations.  Secondly, primary hits could have been 
false positives due to transgenic mutations.  Since expression of ΔARM under 
the OK371-GAL4 driver results in lethality of the animal, the ΔARM transgene 
had to be incorporated into the background of the EMS mutagenized males.  
This could introduce random mutations within the either UAS sequence or the 
ΔARM open reading frame, both of which could result in insufficient ΔARM 
transgenic expression. 
 Over three years, I screened through a total of 20,798 independent 
mutagenized chromosome arms, the majority focused on chromosome 2L 
(Table A2).  While gain of function suppressor screens are powerful genetic 
tools that can identify downstream genes in genetic pathways, this particular 
screen was not fruitful.  Further screening on the remaining chromosome arms 
would be required to reach saturation of the genome, however, time constraints 
forced me to abandon this project.   
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Table A.2.  Total number of chromosome arms screened in gain of function 
dSarmΔARM suppressor screen. 
 
 
 
Materials & Methods 
 
 
Fly Strains 
Flies (D. melanogaster) were kept on standard cornmeal agar supplemented with 
dry yeast at 25°C unless stated otherwise. The following lines were obtained 
from Bloomington Drosophila Stock Center unless otherwise stated: 
X Chromosome: y, w1118, Nrg/FM7c, ElaV-Gal4, hs-FLP, UAS-mCD8::GFP, tub-
GAL80, and FRT19A.  
2nd Chromosome: OK371-Gal4, UAS-mCD8::GFP, FRT40A, FRTG13, tub-
GAL80.  ase-FLP2a and ase-FLP2e (Neukomm et al., 2014), UAS-
dSarmΔARM::Myc (Neukomm et al., 2017) 
 3rd Chromosome:  UAS-mCD8::GFP, FRT2A, FRT42B, tub-GAL80.  ase-FLP3a 
and ase-FLP3b (Neukomm et al., 2014), UAS-dSarmΔARM::GFP (Neukomm et 
al., 2017). 
 
 
Chromosome X 2L 2R 3L Total 
Chromosome 
Arms 
Screened 
210 12,874 493 7221 20,798 
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Mutagenesis screen and wing injury 
Mutagenesis was performed as described previously (Neukomm et al., 2017). In 
brief, males were starved for 12 hours before consuming mutagen (25 mM ethyl 
methane sulphonate (EMS) in 1% sucrose). Males recovered in fresh vials for 12 
hours prior to breeding. Wings were dissected with MicroPoint Scissors (EMS, 
VANNAS Scissors; angled on side, delicate, 5-mm cutting edge, #72933–04) and 
mounted in Halocarbon Oil 27 (Sigma, H8773) on a microscopy slide and 
covered with a coverslip, and immediately used for microscopy.  
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Appendix III:  Pebbled Mutant Neurons Within the Wing Display 
Abnormal Dendrite Morphology  
 
When characterizing the loss of function peb phenotype in axon degeneration, I 
noticed the dendrites of mutant neurons within the wing showed an abnormal 
morphology.  Typically, sensory neurons in the wing vein have a relatively short, 
single dendrite that projects into the socket of a bristle allowing for 
mechanosensation (Neukomm et al., 2014; Singhania and Grueber, 2014).  peb 
mutants, on the other hand, displayed a range of abnormal dendrite 
morphologies which I categorized into four qualitative phenotypes: normal 
(resembles control neurons), mild (short dendrite stump or loss of sensilla at 
dendrite tip), moderate (one single dendrite showing membrane blebbing or 
ectopic growths off of dendrite and/or cell body), and severe morphology 
abnormalities (extremely long dendrite, excessive branching) (Figure A3.1A-B).  I 
measured the length of GFP+ dendrite membrane of peb mutants and found a 
significant increase in average dendrite length, with the largest measuring around 
100 μm in length (Figure A3.1C).   
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Figure A3.1.  Pebbled Mutant Neurons Show Abnormal Dendrite 
Morphology. 
(A) GFP+ sensory neurons in the wing.  Control neuron morphology showing 
normal dendrite morphology.  peb mutant neurons display abnormal outgrowth 
dendritic outgrowth and morphology, categorized into 4 severities: normal, mild, 
moderate, severe.  Scale bar = 10 μm.  (B) Quantification of observed abnormal 
dendrite morphologies (normal = gray, mild = green, moderate = yellow, severe = 
red) in peb mutants, n = 50.  (C) Quantifications of total dendrite length, n = 50. 
**** = p<.0001, unpaired two-tailed t-test. 
 
 
To confirm the abnormal morphology phenotype was due to the loss of 
function peb mutation, I performed a series of rescue experiments.  First, I 
crossed in a copy of the genomic peb by using the pebBAC described in 
CHAPTER III.  Re-expression of endogenous levels of Peb protein completely 
rescued both dendrite morphology as well as the increase in dendrite length, as 
compared to controls (Figure 3.2A-C).  Secondly, I overexpressed the zinc finger 
domain deletion constructs Peb1-8 and Peb10-14 as well as the human homolog of 
peb, hRREB1 (Figure 3.3A-C).  Similar to the results of axotomy, the peb 
dendrite defect was rescued by both the C-terminal zinc finger domains 10-14 
and hRREB1, but not by the N-terminal zinc fingers 1-8.  Together, these data 
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show the dendrite abnormality is in fact an effect of loss of peb in the neuron, and 
suggests these changes are due to Peb’s role in regulating gene transcription. 
 
 
Figure A3.2.  Abnormal Dendrite Morphology is Rescued by Genomic 
pebBAC 
(A) Representative images showing peb mutant dendrite phenotype is rescued 
with re-expression of genomic pebBAC.  No observed change in control dendrite 
morphology with pebBAC.  Scale bar = 10 μm.  (B) Quantification of observed 
abnormal dendrite morphologies (normal = gray, mild = green, moderate = 
yellow, severe = red) in pebBAC rescue, n = 50.  (C) Quantifications of total 
dendrite length, n = 50. **** = p<.0001, One-way ANOVA, Dunnett’s multiple 
comparisons test. 
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Figure A3.3.  The C-Terminal Zinc Fingers and hRREB1 Can Rescue the 
Dendrite Phenotype. 
(A) Representative images showing peb mutant dendrite phenotype is rescued 
with overexpression of known DNA binding C-terminal zinc finger domains 10-14, 
but not N-terminal domains 1-8.  Similarly, overexpression of hRREB1 can 
functionally rescue peb mutant dendrite morphology defect. No observed change 
in control dendrite morphology.  Scale bar = 10 μm.  (B) Quantification of 
observed abnormal dendrite morphologies (normal = gray, mild = green, 
moderate = yellow, severe = red), n = 50.  (C) Quantifications of total dendrite 
length, n = 50. **** = p<.0001, One-way ANOVA, Dunnett’s multiple comparisons 
test. 
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Materials & Methods 
 
Fly strains 
Flies (D. melanogaster) were kept on standard cornmeal agar supplemented with 
dry yeast at 25°C unless stated otherwise. The following lines were obtained 
from Bloomington Drosophila Stock Center: y, w1118, FM7cKr-Gal4, GFP, FRT 19A, 
hs-FLP,tub-Gal80,FRT19A, 5xUAS-mCD8::GFP. OK371-Gal4 (Mahr and Aberle, 
2006), ase-FLP2a and ase-FLP3e (Neukomm et al., 2014), UAS-hRREB1, UAS-
Peb1-8, and UAS-Peb10-14 (gifts from H. Lipshitz, U of Toronto, Toronto, Canada),  
pebBAC was generated by injection of the bacterial artificial chromosome CH321-
46J02 (BAC PAC Resources, Children’s Hospital Oakland Research Institute) 
with Phi31-mediated integration into the genomic locus attP2 (BestGene).  
 
Dendrite Length Analysis 
Dendrites were traced and length was measured using the ImageJ plugin 
NeuronJ (Meijering et al., 2004). 
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